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Abstract
DNA methylation is an essential epigenetic mark crucial for normal mammalian development. This
modification controls the expression of a unique class of genes, designated as imprinted, which are
expressed monoallelically and in a parent-of-origin-specific manner. Proper parental allele-specific DNA
methylation at imprinting control regions (ICRs) is necessary for appropriate imprinting. Processes that
deregulate DNA methylation of imprinted loci cause disease in humans. DNA methylation patterns
dramatically change during mammalian development: first, the majority of the genome, with the exception
of ICRs, is demethylated after fertilization, and subsequently undergoes genome-wide de novo DNA
methylation. Secondly, after primordial germ cells are specified in the embryo, another wave of
demethylation occurs, with ICR demethylation occurring late in the process. Lastly, ICRs reacquire DNA
methylation imprints in developing germ cells. Although much is known about DNA methylation
establishment, DNA demethylation is less well understood. Recently, the Ten-Eleven Translocation
proteins (TET1-3) have been shown to initiate DNA demethylation, with Tet1-/- mice exhibiting aberrant
levels of imprinted gene expression and ICR methylation. Nevertheless, TET1’s role in demethylating ICRs
in the female germline and controlling allele-specific expression remains to be determined. Here, we
examined ICR-specific DNA methylation in Tet1-/- germ cells and ascertained whether abnormal ICR
methylation impacted imprinted gene expression in F1 hybrid somatic tissues derived from Tet1-/- eggs
or sperm. We show that Tet1 deficiency is associated with hypermethylation of a subset of ICRs in germ
cells. Moreover, ICRs with defective germline reprogramming exhibit aberrant DNA methylation and
biallelic expression of linked imprinted genes in somatic tissues. Thus, we define a discrete set of
genomic regions that require TET1 for germline reprogramming and discuss mechanisms for stochastic
imprinting defects.
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ABSTRACT

EXPLORING THE ROLE OF TET1 IN GENOMIC IMPRINTING
Jennifer Myers SanMiguel
Marisa S. Bartolomei
DNA methylation is an essential epigenetic mark crucial for normal mammalian
development. This modification controls the expression of a unique class of genes, designated as
imprinted, which are expressed monoallelically and in a parent-of-origin-specific manner. Proper
parental allele-specific DNA methylation at imprinting control regions (ICRs) is necessary for
appropriate imprinting. Processes that deregulate DNA methylation of imprinted loci cause
disease in humans. DNA methylation patterns dramatically change during mammalian
development: first, the majority of the genome, with the exception of ICRs, is demethylated after
fertilization, and subsequently undergoes genome-wide de novo DNA methylation. Secondly,
after primordial germ cells are specified in the embryo, another wave of demethylation occurs,
with ICR demethylation occurring late in the process. Lastly, ICRs reacquire DNA methylation
imprints in developing germ cells. Although much is known about DNA methylation
establishment, DNA demethylation is less well understood. Recently, the Ten-Eleven
Translocation proteins (TET1-3) have been shown to initiate DNA demethylation, with Tet1-/mice exhibiting aberrant levels of imprinted gene expression and ICR methylation. Nevertheless,
TET1’s role in demethylating ICRs in the female germline and controlling allele-specific
expression remains to be determined. Here, we examined ICR-specific DNA methylation in Tet1-/germ cells and ascertained whether abnormal ICR methylation impacted imprinted gene
expression in F1 hybrid somatic tissues derived from Tet1-/- eggs or sperm. We show that Tet1
deficiency is associated with hypermethylation of a subset of ICRs in germ cells. Moreover, ICRs
with defective germline reprogramming exhibit aberrant DNA methylation and biallelic
expression of linked imprinted genes in somatic tissues. Thus, we define a discrete set of genomic
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regions that require TET1 for germline reprogramming and discuss mechanisms for stochastic
imprinting defects.
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CHAPTER 1: INTRODUCTION
All cells within an organism contain the same genetic information, yet the
phenotypes of these cells vary drastically across tissues and stages of development.
Epigenetic control of gene expression allows for the distinct usage and expression of
genes, ultimately giving rise to the diverse set of cells and functions within the body.
Epigenetics broadly encompasses heritable mechanisms that lead to changes in gene
expression without altering the underlying DNA sequence, such as nucleosome
positioning and composition, histone post-translational modifications, non-coding
RNAs, and DNA methylation. DNA methylation, the best studied epigenetic
modification, involves the covalent addition of a methyl group to the carbon 5 position
on cytosine (5mC), typically within the context of a cytosine guanine dinucleotide,
connected by a phosphodiester bond (CpG). This epigenetic mark is involved in a variety
of functions in the mammalian genome, including X chromosome inactivation, gene
silencing, genomic stability, cellular identity, and genomic imprinting.

1.1 DNA methyltransferases add and maintain DNA methylation
DNA methylation is a catalytic reaction carried out through the use of the methyl
donor, S-adenosylmethionine (SAM). This covalent modification of cytosine residues
typically occurs in a CpG context, although non-CpG methylation has been observed,
particularly in the brain and in oocytes (Guo et al., 2014a; Smith et al., 2012).
Collectively, the DNA methyltransferase enzymes (DNMTs) add and maintain levels of
DNA methylation throughout the genome (Lyko, 2018).
The first identified family member of DNMTs was DNMT1. Dnmt1 homozygous
null animals die during midgestation, indicating the importance of DNA methylation
during development (Li et al., 1992). DNMT1 maintains DNA methylation by copying
1

existing methylation patterns onto newly replicated DNA strands. Evidence suggests that
DNMT1 can methylate cytosines in a de novo fashion (Vertino et al., 1996), although the
enzyme’s preferred substrate is hemimethylated DNA (Fatemi et al., 2001). The
maintenance function of DNMT1 is accomplished by binding to ubiquitin-like with PHD
and ring finger domains 1 (UHRF1, also known as nuclear protein, 95 kDa
(NP95))(Bostick et al., 2007). UHRF1 binds to proliferating cell nuclear antigen (PCNA),
the sliding clamp of the DNA replication fork (Uemura et al., 2000). UHRF1 additionally
is recruited to the replication fork by DNA ligase 1 (LIG1) (Ferry et al., 2017). Thus,
DNMT1 is targeted to the replication machinery, which explains the mechanism behind
its maintenance function.
Evidence for additional DNA methyltransferase enzymes became apparent when
residual DNA methylation was observed in Dnmt1 null embryonic stem cells (ESCs) and
mice (Li et al., 1993a). Through homology searches, two additional methyltransferases
were discovered, called DNMT3A and DNMT3B (Okano et al., 1998). They were
designated the de novo methyltransferases because they can add DNA methylation with
equal affinity for non-methylated and hemimethylated DNA substrates, but they have
also been shown to have some maintenance functions as well (Okano et al., 1998; Rhee et
al., 2000). Dnmt3a null mice die approximately four weeks after birth, whereas Dnmt3b
homozygous knockout animals die after E9.5 (Okano et al., 1998; Okano et al., 1999).
The DNMT3L protein lacks a catalytic domain but binds to both of the de novo
methyltransferases and acts as a stimulatory cofactor. DNMT3L contains a plant
homeodomain-like domain (PHD) that recognizes unmethylated histone 3 lysine 4
(H3K4) residues and therefore is important for targeting DNMT3A and DNMT3B to
chromatin. Dnmt3l homozygous knockout animals also die around E9.5 (reviewed in
(Dan and Chen, 2016; Jurkowska and Jeltsch, 2016)). Interestingly, mouse ESCs can
2

tolerate the combined deletion of DNTM1, DNMT3A, and DNMT3B despite the near
complete abolishment of DNA methylation. However, these cells have compromised
differentiation, emphasizing the critical role of DNA methylation in development
(Tsumura et al., 2006).
Lastly, a rodent-specific DNA methyltransferase gene, Dnmt3c, was recently
discovered (Barau et al., 2016). This gene resulted from a duplication of Dnmt3b.
DNMT3C is responsible for adding DNA methylation to promoters of young
retrotransposons in the male germline. Dnmt3c homozygous mutant mice develop
normally but are sterile, due to azoospermia caused by disruptions of chromosome
synapsis during meiotic prophase I. Thus, this gene is important for normal male fertility
in mice (Barau et al., 2016).

1.2 Genomic Imprinting
1.2.1 Definition

Genomic imprinting is a phenomenon where a subset of genes in the mammalian
genome is expressed from a single parental allele. We contrast this definition of
imprinted genes with genes that show allelically-biased expression, as the mechanism
governing biased expression is unclear. Currently, approximately 150 imprinted genes in
mice and about 100 in humans have been identified, many of which are imprinted in
both species. Imprinted genes tend to be found in clusters, and this allows for their
coordinated regulation by a cis-acting regulatory element called an imprinting control
region (ICR). ICRs are characterized by parental-allele-specific DNA methylation, which
regulates their unique expression pattern (Barlow and Bartolomei, 2014). I describe the
identification and characterization of ICRs below.

3

1.2.2 Historical Perspective

The inequivalence of the paternal and maternal genomes was known well before
the identification of imprinted genes. Nuclear transfer experiments in mouse
demonstrated that both maternal and paternal contributions were necessary for viable
pups, whereas uniparental embryos failed to develop to term (McGrath and Solter, 1984;
Surani et al., 1986). Additionally, it was shown that uniparental disomies in specific
genomic regions were detrimental or gave rise to phenotypes dependent upon the
parent-of-origin, in both mouse and humans (Cattanach and Kirk, 1985; Searle and
Beechey, 1978). Lastly, a subset transgenic mouse lines exhibited parent-of-origin
specific expression of the transgene (Swain et al., 1987), suggesting that some genomic
sequences could be differentially modified in the germline (Barlow and Bartolomei,
2014).
The first three imprinted genes were described in the early 1990s: insulin-like
growth factor receptor 2 (Igf2r) (Barlow et al., 1991), H19 (Bartolomei et al., 1991), and
insulin-like growth factor 2 (Igf2) (DeChiara et al., 1991). Two of these genes (H19 and
Igf2) are linked (Figure 1) (Zemel et al., 1992), which prompted the original suggestion
that imprinted genes are clustered. Once imprinted genes were identified, the question of
how this unique expression pattern is conferred was pursued. It was hypothesized that a
specific sequence could be marked epigenetically, or that a sequence could be recognized
by a trans-acting epigenetic regulatory protein. Given the suggestion that imprints must
be set in the germline, maintained through fertilization, and erased in embryonic germ
cells, it was speculated that DNA methylation may be the epigenetic mark that fit these
criteria (DeChiara et al., 1991). Definitive evidence that DNA methylation regulates
imprinted gene expression came from a mouse knockout model of the DNA
methyltransferase 1 (Dnmt1) gene, which resulted in DNA hypomethylation and loss of
4

imprinted gene expression (Tables 1.1 and 1.2) (Li et al., 1993b). Consequently, for each
imprinted loci, rigorous searches for the specific sequence that was differentially DNA
methylated and met the criteria of imprints were undertaken. For example, at the H19
locus, a region of paternal-specific methylation was found in a 7-9 kilobase region
encompassing part of the H19 gene itself, as well as a 5’ region (Bartolomei et al., 1993).
This region was further refined to a 2 kilobase region 5’ of H19 that was found to be DNA
methylated in sperm but not oocytes, and this differential methylation was maintained
during development (Tremblay et al., 1995; Tremblay et al., 1997). More recently,
genome-wide analyses using F1 hybrid animals have confirmed existing regions as well
as uncovered new differentially methylated regions (DMRs) in mice (Xie et al., 2012).
1.2.3 Mechanisms of ICR Functions

Ultimately, the test of whether a DMR is an ICR and conferred imprinted
expression of one or multiple genes was undertaken using genetic deletion and
mutations in mice. Loss of imprinted gene expression upon deletion of a DMR provided
evidence that the sequence was causal in conferring imprinted gene expression—these
regions are designated as ICRs. How these ICRs control monoallelic expression is still
not fully understood, but mechanisms at two or more imprinted loci have been carefully
dissected and thus two predominant models of imprinting have been described: the
enhancer blocking model at the H19/Igf2 locus and the long noncoding RNA model at
the Igf2r locus(Barlow and Bartolomei, 2014). These models are by no means exhaustive
and thus the mechanisms across other imprinted loci remain to be determined. I
describe the two imprinting models below.
The H19 ICR is DNA methylated exclusively on the paternal allele (Tremblay et
al., 1997). CCCTC binding factor (CTCF), a multifunctional, methylation-sensitive
architectural protein, binds to the unmethylated maternal ICR and forms a functional
5

insulator blocking the access of downstream enhancers from interacting with the
upstream Igf2 promoter (reviewed by Singh et al., 2012). On the paternal allele, DNA
methylation at the ICR prevents CTCF binding, allowing the downstream enhancers to
interact with the Igf2 promoter and promote transcription. The DNA methylation from
the ICR spreads into the H19 promoter, silencing H19 expression (Davis et al., 2000)
(Fig 1.1). A paternally inherited 1.6 kb deletion of the H19 DMR in mice caused activation
of paternal H19 expression and concurrent repression of paternal Igf2 expression
whereas the maternal inheritance of the same deletion caused the opposite effect: H19
expression was repressed, whereas Igf2 expression was activated on the maternal allele
(Thorvaldsen et al., 1998). This study highlights the crucial function of the H19 ICR for
regulating monoallelic expression of both H19 and Igf2.
In an alternative model, certain other ICRs overlap with promoters for noncoding
RNAs. For example, the paternally unmethylated Igf2r ICR overlaps the promoter for
the paternally-expressed Airn, the KvDMR shares sequence with the promoter for the
paternally-expressed Kcnq1ot1, and the Snrpn ICR overlaps with the promoter for
Ube3a-ats, (Barlow and Bartolomei, 2014). At the aforementioned Igf2r locus, the ICR is
in an intron of the Igf2r gene (Stöger et al., 1993). The ICR is methylated on the
maternal allele, silencing the expression of the long noncoding RNA, Airn. On the
paternal allele, the ICR is unmethylated, allowing transcription of Airn, which interferes
with the transcription of Igf2r in cis by transcriptional interference at the Igf2r promoter
(Latos et al., 2012). This model has also suggested to be partially how the KvDMR
functions but is not sufficient to explain imprinting across the entire locus in certain
tissues, such as the heart (Barlow and Bartolomei, 2014; Korostowski et al., 2012).
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1.2.5. Secondary DMRs

In contrast to an ICR that gains DNA methylation in the germline and controls
the monoallelic expression of imprinted genes in the locus, certain imprinted loci contain
additional DMRs that gain methylation later in development or gain methylation in the
germline, lose methylation during preimplantation, and are remethylated postimplantation. These are known as secondary or somatic DMRs. For example, at the Igf2r
locus, two DMRs were identified using southern blots. DMR2 serves as the primary ICR
that gains methylation in the germline on the maternal allele. In contrast, DMR1 is
localized to the promoter of Igf2r and the paternal allele that carries DNA methylation is
silent (Stöger et al., 1993). This DMR is unmethylated in sperm and ESCs, but gains
methylation postimplantation and this methylation is maintained in the adult (Stöger et
al., 1993). To understand the role DMR1 plays in imprinted gene expression, a mouse
model was created that replaced the endogenous Igf2r promoter with the thymidine
kinase promoter or deleted the promoter entirely. In both cases, imprinted expression of
Airn, Slc22a2 and Slc22a3 remained intact, arguing against a role of DMR1 in
maintaining imprinted expression. However, the alleles lacking the endogenous
promoter aberrantly gained methylation on the maternal allele, indicating the sequences
contained in this promoter normally repress methylation on the maternal allele in the
wild-type situation (Sleutels et al., 2003).
The KvDMR locus in mice expresses a long noncoding RNA, Kcnq1ot1, from the
paternal allele. The promoter of Kcnq1ot1 is unmethylated on the paternal allele and is
associated with Kcnq1ot1 expression (Smilinich et al., 1999). DNA methylation at the
promoter of Kcnq1ot1 on the maternal allele suppresses its expression and lack of
transcription allows an antisense gene, Kcnq1 to be expressed (Mancini-DiNardo et al.,
2006). Cdkn1c is also expressed maternally. Interestingly, almost the entire gene body of
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Cdkn1c is located within a CpG island (CGI), known as the Cdkn1c DMR, methylated on
the paternal allele. This DMR, like the Igf2r DMR1, gains methylation not in sperm, but
later in somatic tissue. Using polymorphisms in F1 hybrid tissue, Bhogal and colleagues
determined the parental specific methylation of the Cdkn1c DMR begins 650 bp 5’ to the
start of the gene and ends 3’ of exon 2, coinciding with the 3’ end of the CGI (Bhogal et
al., 2004). In a mouse model where the KvDMR had been deleted and inherited on the
paternal allele, the Cdkn1c DMR lost DNA methylation on the paternal allele and Cdkn1c
itself was aberrantly biallelically expressed (Bhogal et al., 2004). To test the hypothesis
that methylation at the Cdkn1c DMR controls allele specific expression of Cdkn1c, the
authors examined allele-specific expression in early embryos, before the acquisition of
the somatic DNA methylation at the DMR. However, Cdkn1c was still monoallelically
expressed despite the lack of DMR methylation. This supports the idea that the Cdkn1c
DMR is not responsible for initiating monoallelic expression of Cdkn1c. Lastly, in E9.5
Dnmt1 null embryos, Cdkn1c was also biallelically expressed, suggesting that DNA
methylation at the Cdkn1c DMR is required to maintain imprinted expression (Bhogal et
al., 2004; Caspary et al., 1998). Thus, somatic DMRs may influence imprinted
expression depending on the locus.
1.2.6. Histone modifications at ICRs

While DNA methylation is perhaps the most well understood mark at ICRs, it is
not the only epigenetic modification at these loci. Allele-specific histone modifications
are often associated with either the DNA methylated or unmethylated allele depending
on the modification. For example, at the Snrpn locus, activating histone 3 (H3) lysine 4
(K4) methylation (me) as well as H3K9 and K14 acetylation (ac) are enriched on the
paternal, non-DNA methylated ICR in brain tissue, where Snrpn is highly expressed
(Fournier et al., 2002). Conversely, the DNA methylated maternal allele is enriched in
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H3K9 dimethylation (me2) (Fournier et al., 2002). This association with active, open
chromatin acetylation marks is generally true across not only the paternal allele of the
Snrpn ICR, but across the paternal alleles of many other maternally DNA methylated
ICRs, including Peg1, Zac1, Gnas1a, Peg3, Snrpn, KvDMR1, Igf2r, and U2af1 in mouse
embryonic fibroblasts (MEFs) (Singh et al., 2010).
Histone modification status has also been investigated at the three known
paternally methylated ICRs, H19, IG-DMR, and the Rasgrf ICR in F1 hybrid embryonic
stem cells (ESCs). In all three cases, the unmethylated paternal allele was enriched in
H3K4me2 and H3ac. H19 showed strong enrichment for H4K20me3 (a repressive
modification typical of pericentric chromatin) as well as H3K9me3. However, no
H3K27me3 was found at either allele of the ICR (Delaval et al., 2007). These patterns of
histone modifications were the same at the IG-DMR and the Rasgrf ICR, with the
exception that H3K27me3 was found on the unmethylated allele at the Rasgrf locus
(Delaval et al., 2007). H3K9me3 was also strongly enriched on the DNA methylated
paternal allele at the H19 ICR in MEFs, whereas neither H3K27me3 nor symmetrically
demethylated (me2s) H4 arginine 3 (R3) showed evidence of allele-specific enrichment
in this cell type (Verona et al., 2008).
To understand if these allele-specific modifications are a cause or consequence of
transcription at the H19 locus, Verona et al. used F1 hybrid MEFs and neonatal livers
harboring a 3.8 kb deletion that spans the entire H19 ICR and the intervening sequence
between the ICR and the promoter. In this system, when the deletion is inherited
maternally, H19 is not expressed in MEFs, but is expressed in neonatal liver. The
investigators found that activating histone modifications at the promoter were only
present in neonatal liver where H19 was expressed, but not in MEFs, regardless of the
presence of the 3.8 kb deletion. This indicates that allele-specific histone modifications,
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at least at this locus, are established due to transcription and not due to the presence of
the ICR (Verona et al., 2008). Interestingly, failure to reprogram these allele-specific
histone modifications at this locus may explain a paternal-specific embryonic lethality
phenotype in a mouse model where the human H19 ICR was knocked into the
endogenous mouse locus (Hur et al., 2016).
1.2.7 Imprinted genes in health and disease

The importance of proper monoallelic expression of imprinted genes is
exemplified by their misregulation in human imprinting disorders and the abnormal
phenotypes described in various genetic mouse models where imprinted gene dosage or
ICR mutations have been constructed. For example, in patients where there is an
abnormal gain of methylation at the H19 ICR (in humans, imprinting control region 1
(IC1), H19 is silenced and IGF2 is biallelically expressed, resulting in an overgrowth
disorder known as Beckwith-Wiedemann Syndrome (Cooper et al., 2005). This
epimutation accounts for about 5%-10% of Beckwith-Wiedemann patients, whereas
hypomethylation at the KvDMR (in humans: IC2) accounts for nearly 50% of these
patients (Elhamamsy, 2017). Other abnormalities including uniparental disomy, ICR
duplications or deletions, as well as deletions in regulatory regions also contribute to
imprinting disorders such as transient neonatal diabetes, Silver-Russell syndrome,
Prader-Willi syndrome, Angelman syndrome, and Pseudohypoparathyroidism type 1b
(Elhamamsy, 2017). Together, these disorders highlight the tight regulation and
expression required of imprinted genes for normal development. Moreover, imprinting
disorders underscore the need to further understand how imprinted genes are regulated
to begin to connect patient molecular diagnoses to phenotypes, which could aid in
potential therapeutic discoveries in the future.
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1.2.5 ICR methylation dynamics overview

While DNA methylation is a stable and heritable epigenetic mark, this
modification is also highly dynamic, particularly during mammalian development. The
global changes in DNA methylation after fertilization and in primordial germ cells
(PGCs) are central to embryonic epigenetic reprogramming. Intriguingly, parent-specific
DNA methylation marks at ICRs are also dynamically regulated during development (Fig
1.2). DNA methylation imprints are first set in the germline and maintained through
fertilization and preimplantation development, despite a nearly complete demethylation
of the genome. DNA methylation imprints are then erased in the developing PGCs of the
embryo, which allows the establishment of sex-specific marks in the gametes
(Macdonald and Mann, 2014). Below, I describe the epigenetic reprogramming, evidence
for active DNA demethylation, details regarding the TET family of proteins and TDG,
followed by a summary of the current knowledge regarding both reprogramming of the
genome in general, as well as reprogramming of ICRs during embryonic development.

1.3 Epigenetic Reprogramming
Reprogramming in mammals consists of two main waves: the first occurs in the
zygote and preimplantation embryo, and the second, in the developing germ line. In both
cases, these waves include dramatic loss of DNA methylation, followed by subsequent de
novo methylation. Histone modifications are also dynamically remodeled during these
two waves of reprogramming and there may be mechanistic links between these two
epigenetic processes (Hajkova et al., 2008; Saitou and Yamaji, 2012). Thus, epigenetic
reprogramming refers to broad changes in epigenetic modifications, such as DNA
methylation and histone modifications, which lead to changes in gene expression and
cell potency. Here, I primarily focus on DNA methylation changes.
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The concept of epigenetic reprogramming was initially recognized by Art Riggs
when he proposed a role for DNA methylation in facilitating the process of X inactivation
in female mammals (Riggs, 1975). In the 1980s, Jähner and Jaenisch observed that
changes in gene expression were correlated with DNA methylation and postulated that
DNA methylation “may be a condition for ‘resetting’ the genome” (Jähner and Jaenisch,
1984). Later, Monk et al. found that while sperm DNA is highly methylated, blastocysts
had very low methylation. Gains of DNA methylation were observed from the blastocyst
stage to embryonic day (E)6.5 in the epiblast. By E12.5 and E14.5, PGCs exhibited low
levels of DNA methylation, while the somatic DNA methylation levels remained similar
to E6.5 epiblasts. Monk and colleagues also observed methylation increases in certain
repetitive sequences in male germ cells at E16.5 but not in female germ cells (Monk et al.,
1987). This study demonstrated that the early embryo and the germline were likely
undergoing dynamic DNA methylation changes.
Why would these reprogramming events be necessary for early mammalian
development? In mammals, germ cells are specified from the epiblast (Anderson et al.,
2000; Ginsburg et al., 1990). Therefore reprogramming of DNA methylation is required
to erase the epiblast-specific pattern of DNA methylation enabling the subsequent
acquisition of sperm- or egg-specific epigenetic marks (Monk et al., 1987). This is also
true for the zygote, which must erase the cell-type specific DNA methylation marks that
define the sperm and oocyte in order to facilitate DNA methylation patterns
characteristic of somatic cells. DNA methylation erasure is also postulated to ensure that
abnormal epigenetic marks are not transmitted to the next generation (Heard and
Martienssen, 2014; Surani, 1999). Lastly, erasure of DNA methylation in the fetal germ
line provides a blank slate so that parental specific imprinting marks can be properly
established according to the sex of the developing embryo (Tada et al., 1997).
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1.3.1 Evidence for active DNA demethylation

Breaking a carbon-carbon bond between the methyl group and the cytosine ring
was thought to be impossible given the extreme thermodynamic input required in a
physiological setting. However, evidence that DNA methylation could be removed was
first demonstrated by Gjerset and Martin, who described demethylation in nuclear
extracts from erythroleukemia cells where 5mC was replaced with an unmodified
cytosine. This demethylation occurred in the absence of DNA synthesis, was proportional
to the amount of protein added to the reaction, and was abolished by the addition of both
proteinase K and heat inactivation, indicating an enzymatic activity (Gjerset and Martin,
1982). This demethylation was specific to DNA methylated CpGs (Razin et al., 1986;
Razin et al., 1988). Likewise, HeLa cell extract exhibited such an activity and additionally
demonstrated newly generated abasic sites in the template, indicating glycosylase
involvement (Vairapandi and Duker, 1993). Lastly, it was shown that fusion of somatic
cells with germ cells caused extensive DNA demethylation of somatic nuclei (Surani,
1999). This early evidence pointed to an active process whereby 5mC is replaced without
DNA replication. While many candidate proteins and pathways have been described as
the origin of a demethylating activity (for further information see (Bochtler et al., 2017;
Dean, 2016; Ooi and Bestor, 2008)), one of the most promising discoveries involves a
family of proteins called the Ten-eleven translocation (TET) family, described below.
1.3.3 Oxidative Demethylation by TET1, TET2, and TET3

In 2002, a fusion protein containing part of the mixed lineage leukemia (MLL)
histone methyltransferase and a previously uncharacterized protein, called leukemiaassociated protein with a CxxC domain (LCX), was described in patients with MLL (Ono
et al., 2002). However, it was not until 2009 that the relevance of this new protein
became apparent (Kriaucionis and Heintz, 2009; Tahiliani et al., 2009). A newly
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described cytosine modification in mammals, 5-hydroxymethylcytosine (5hmC), was an
oxidation product of 5mC and was reported in Purkinje neurons and mouse ESC DNA
(Kriaucionis and Heintz, 2009; Tahiliani et al., 2009). Crucially, Tahiliani et al.
demonstrated that LCX, now known as ten-eleven translocation methylcytosine
dioxygenase 1 (TET1), was responsible for generating 5hmC and that this activity
depended on a functional catalytic domain as well as Fe(II) and alpha-ketoglutarate. The
two other TET family members, TET2 and TET3, were also shown to catalyze the 5hmC
reaction, and all three family members can further oxidize 5hmC to 5-formylcytosine
(5fC) and 5-carboxylcytosine (5caC) (He et al., 2011; Ito et al., 2010; Ito et al., 2011). The
use of Dnmt3a/3b null mice revealed a reduction in 5fC, suggesting that 5fC
accumulation was likely dependent on 5mC first being oxidized by TET to 5hmC
(Pfaffeneder et al., 2011). Together, these important studies supported the idea that the
TET family proteins are responsible for 5mC oxidation and thus led to the prevailing
view that TETs are a major regulator of DNA demethylation.
1.3.4 TETs: Gene and Protein Structure and Function

All three TET family members contain a cysteine-rich domain and a doublestranded beta helix domain, together forming the catalytic domain of these proteins
(Kohli and Zhang, 2013). The crystal structure of the TET2 catalytic domain revealed
that the enzyme works by using a base-flipping mechanism. The methyl group of
cytosine does not participate in the DNA-enzyme interaction and thus the active site can
accommodate the larger oxidized cytosine bases (Hu et al., 2013). The active site of the
TET enzyme does show different efficiencies of hydrogen abstraction, with 5hmC and 5fC
adopting positions less favorable for the reaction. This structural finding indicates that
catalytic efficiency is better converting from mC to 5hmC, than from 5hmC to 5fC, or
from 5fC to 5caC (Hu et al., 2015).
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Both TET1 and TET3 contain a CxxC domain that lacks the KFGG motif found in
some other CxxC domain containing proteins, such as Dnmt1, whereas TET2 lacks this
domain entirely. Instead, IDAX, a genomic neighbor of TET2, contains this domain,
indicating that IDAX may have arisen from a gene duplication event (Ko et al., 2013).
This structural difference is thought to create a more flexible mode of DNA binding
compared to CxxC domain proteins containing the KFGG motif (Long et al., 2013).
Studies of the TET CxxC domain have led to conflicting reports on its effect on the
preferred sequence context of TET (Frauer et al., 2011; Xu et al., 2011; Zhang et al.,
2010). Recent data supports the idea that the human TET1 CxxC domain will bind CpN
with a slight preference for CpG, and only weakly binds hemi-methylated CpG sites, or
hemi-5hmCpG sites (Xu et al., 2018; Zhang et al., 2017). TET1 ChIP-seq data from ESCs
does demonstrate that TET1 localizes to regions of high CpG density, including DNA
hypomethylated CpG-rich promoters (Williams et al., 2011; Wu et al., 2011a).
In mice, the Tet1 gene is located on chromosome 10 and has two annotated refseq
isoforms. These isoforms contain 11 or 12 exons, respectively, and the entire gene spans
75,445 base pairs. Interestingly, additional Tet1 isoforms have been recently reported in
the literature, including a N-terminal truncation that initiates transcription from exon 2
using an alternative promoter. This shortened isoform lacks the upstream sequence and
CxxC domain of TET1. The full length isoform is expressed in ESCs, PGCs, and early
embryos, while the truncated form is expressed later in development and in adult tissues
(Zhang et al., 2016b). Zhang and colleagues expressed Flag-tagged full-length and short
isoforms, as well as different isolated domains of TET1 in the background of Tet1;Tet2
double knockout ESCs. They found that the short isoform of TET1 could still bind
chromatin, although to a lesser extent than the full-length isoform. Of note, the Nterminal domain without the CxxC domain was also found to bind to chromatin. Thus
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the authors conclude that the N-terminal domain, named before CxxC domain (BC),
plays an additional, previously unappreciated role in chromatin binding (Zhang et al.,
2016b).
1.3.5 TDG and base excision repair

Thymine DNA glycosylase (TDG) was originally described for its DNA glycosylase
activity on G/T mismatches. Nevertheless, there had been hints that this enzyme was
also involved in DNA demethylation (Jost et al., 2001; Vairapandi and Duker, 1993; Zhu
et al., 2000). It is now appreciated that TDG cleaves 5fC and 5caC rapidly in vitro,
whereas the enzyme shows no activity on 5hmC (He et al., 2011). This cleavage results in
an abasic site that is subsequently repaired by base excision repair. Indeed, inhibition of
base excision repair proteins downstream of TDG such as apurinic/apyrimidinic
endonuclease 1 (APE1) or poly(ADP-ribose) polymerase 1 (PARP1) (Ciccarone et al.,
2012; Hajkova et al., 2010; Kawasaki et al., 2014) in cultured mouse zygotes leads to
accumulations of 5mC in zygotes (Hajkova et al., 2010). Other experiments that
inhibited PARP pharmacologically in pregnant dams also led to increases in DNA
methylation at certain imprinted genes in fetal PGCs. TDG null embryos die around
E12.5 (Cortázar et al., 2011; Cortellino et al., 2011), further underscoring this protein’s
role in a critical developmental pathway.

1.4 Preimplantation DNA Methylation Reprogramming
1.4.1 Genome-Wide DNA Demethylation

After fertilization, the paternal pronucleus undergoes rapid demethylation before
the onset of DNA replication whereas the maternal genome demethylates more slowly
over multiple cell divisions. These kinetics indicate that the paternal genome is actively
demethylated whereas the maternal genome is demethylated in a passive, replicationdependent manner (Seah and Messerschmidt, 2017). Multiple groups have described
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TET3 activity as well as the accumulation of all three oxidized cytosine bases in both
parental pronuclei (Shen et al., 2014; Tsukada et al., 2015). This accumulation depends
on TET3 as well as TET1 as depletion of TET3 in the oocyte leads to an impairment of
5hmC accumulation, whereas depletion of both TET1 and TET3 leads to a complete
absence of 5hmC at the 8-cell stage (Gu et al., 2011; Kang et al., 2015; Wossidlo et al.,
2011). It is likely that 5hmC, 5fC, and 5caC are removed by passive dilution as these
bases are only found on one half of the paternally-derived chromatids (Inoue and Zhang,
2011; Inoue et al., 2011).
Interestingly, the oxidation of 5mC in the zygote may not be necessary for the
global demethylation as previously thought. Shen and colleagues demonstrated that
demethylation still occurred in paternal pronuclei despite a conditional oocyte-specific
Tet3 knockout, suggesting that zygotic TET3 was partially responsible for demethylating
the paternal genome and that only certain regions were dependent on TET3 for 5mC
oxidation. When wild-type zygotes were treated with the replication inhibitor
aphidicolin, 5mC levels did not decrease, despite the continued activity of TET3 as
evidenced by the presence of the oxidized bases 5hmC, 5fC, and 5caC, suggesting a role
for DNA replication (Shen et al., 2014). Further evidence that 5hmC accumulation does
not drive DNA demethylation was demonstrated by precise staging of zygotes and
detection of 5mC and 5hmC using antibody staining (Amouroux et al., 2016). This
experiment demonstrated that the global wave of DNA demethylation is complete by
pronuclear stage (PN)3, corroborating earlier reports (Amouroux et al., 2016; Santos et
al., 2002). It was further demonstrated that the accumulation of 5hmC was dependent
on previously underappreciated activities of both maternally inherited DNMT3A and
DNMT1 (Amouroux et al., 2016). Thus, the role of TET3 in the zygote may not be
connected to the initial DNA demethylation of the genomes after fertilization, but may be
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serving to protect normally unmethylated regions from inappropriate acquisition of DNA
methylation (Amouroux et al., 2016).
1.4.2 Imprinted Regions Escape Preimplantation DNA Methylation Reprogramming

Even before the discovery of imprinted genes, it was appreciated that the
functional differences between maternal and paternal genomes remained intact during
genome-wide demethylation that occurred in the zygote (Surani et al., 1986). Now, it is
clear that a generalized feature of ICRs is the maintenance of DNA methylation and
simultaneous protection from demethylation after fertilization. How are ICRs protected?
Developmental pluripotency associated 3 (DPPA3, also known as STELLA or PGC7) is a
highly expressed protein in oocytes, PGCs, and both pronuclei in the zygote (Sato et al.,
2002). When DPPA3 is deleted, both maternal and paternal genomes lose methylation.
This is also apparent for ICRs. Dppa3 maternal-null zygotes partially lose imprinted
DNA methylation at the H19 (Table 1.1), Peg1, Peg3, Peg10, and Rasgrf1 ICRs. In
contrast, the IG-DMR, Snrpn, and Peg5 ICRs remained methylated, indicating that
DPPA3 is partially responsible for the maintenance of DNA methylation at a subset of
ICRs (Nakamura et al., 2007). It has been suggested that DPPA3 exerts a maintenance
function by binding to and inhibiting the activity of the C-terminal catalytic domain of
TET2 and TET3 (Bian and Yu, 2014). Bian and Yu also demonstrated that approximately
60% of TET3 chromatin immunoprecipitation followed by deep sequencing (ChIP-seq)
peaks overlapped with DPPA3 peaks, and vice versa. Analysis of the DNA sequence
bound by DPPA3 indicated a motif preference found in the ICRs of Peg1, Peg3, Peg10,
and H19. (Bian and Yu, 2014). However, results from this study should be interpreted
with caution as the co-immunoprecipitations were conducted in human embryonic
kidney 293T cells (Bian and Yu, 2014), which express low levels of TET proteins
endogenously (Grosser et al., 2015; Wu and Zhang, 2011). Additionally, DPPA3 can bind
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to H3K9me2, which is enriched on the methylated allele of imprinted genes, further
explaining the targeting and protection of ICRs afforded by DPPA3 binding (Nakamura
et al., 2012).
Perhaps a more compelling factor that is involved in the protection of ICR
methylation during preimplantation development is zinc finger protein 57 (ZFP57) (Li et
al., 2008). Null embryos from Zfp57 heterozygous matings show a partial lethality
phenotype (Li et al., 2008). Maternal-zygotic null zygotes exhibit changes in total
expression of imprinted genes regulated by the IG-DMR and loss of ICR DNA
methylation, but the ICR DNA methylation and imprinted gene expression at the
H19/Igf2 locus are unaffected (Table 1.1). The maternal-zygotic Zfp57 mutants also lose
methylation at the Snrpn, Peg1, Peg3, and Peg5/Nnat ICRs (Li et al., 2008).
Interestingly, ZFP57 binds only to the methylated ICR and this methylation is necessary
for its binding (Quenneville et al., 2011; Strogantsev et al., 2015). The allele-specific
binding is neither observed at secondary DMRs (Fig 1.2) nor at DMRs unrelated to
imprinted genes in the germline (Strogantsev et al., 2015). ChIP-seq experiments
demonstrated that a six-base pair motif, TGCCGC, is found at almost all of the known
ICRs. This motif is sufficient to maintain DNA methylation at the Snrpn ICR when it is
integrated away from its endogenous locus, but mutations of the motif cause a loss of
methylation maintenance in this system (Anvar et al., 2015).
The ability of ZFP57 to serve an ICR methylation maintenance function lies in its
interacting partners. ZFP57 binds tripartite motif-containing 28 (TRIM28, also known
as KAP1 or TIF1-beta), which is a corepressor that recruits repressive histone modifiers
like histone deacetylases (HDACs), the histone methyltransferase SETDB1, and DNA
methyltransferases to chromatin (Messerschmidt, 2012). The recruitment of maternal
DNMT1 is essential for imprint maintenance as maternal-zygotic Dnmt1 mutation also
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leads to demethylation at ICRs in zygotes (Hirasawa et al., 2008). Trim28 hypomorphic
zygotic mutants maintain imprinted DNA methylation at the IG-DMR, but loss-offunction zygotic mutants lose DNA methylation at IG-DMR in a partially penetrant
manner, indicating the amount of TRIM28 is important for ICR protection.
Hypomorphic maternal-zygotic Trim28 mutants exhibit biallelic expression of H19
(Table 1.1), Gtl2, and Snrpn (Alexander et al., 2015). Additionally, single cell methylation
analysis of six ICRs (H19, IG-DMR, Igf2r, Snrpn, Peg3, Nnat), demonstrated that
maternal loss of Trim28 resulted in highly variable demethylation of these ICRs within
the same blastomere (Tables 1.1 and 1.2). This result suggests that maternal Trim28
deficiency leads to an incompletely penetrant ICR demethylation phenotype
(Lorthongpanich et al., 2013).

1.5 Peri-implantation De Novo Methylation of the Genome
Following zygotic epigenetic reprogramming, the blastocyst is hypomethylated
with the exception of imprinted genes, Intracisternal A particle elements (IAPs), and a
subset of gene promoters, including genes enriched in functions such as gamete
generation and sexual reproduction (Kim et al., 2004; Saitou et al., 2012). Beginning at
the early blastocyst stage and culminating by E6.5, the genome gains DNA methylation
globally while certain CpG islands remain hypomethylated (Saitou et al., 2012; Smith et
al., 2012). PGCs are specified from cells with this aforementioned methylated state,
which then must be subsequently erased, as discussed in the following section.

1.6 PGC DNA Methylation Reprogramming
PGCs are specified at E7.25 in the mouse. After specification, PGCs proliferate
and migrate from the epiblast towards the genital ridge. PGCs then undergo a second
wave of demethylation to erase the epiblast cell fate and facilitate germ-cell fate. Here,
DNA is demethylated at ICRs (Saitou and Yamaji, 2012). First, levels of genome-wide
20

methylation decrease as early as E8.0, while some regions maintain DNA methylation. A
later, second wave targets these initially resistant regions, leading to the lowest levels of
methylation in PGCs by E13.5. This two-step demethylation process may be important
for suppressing premature differentiation of the germline (Hargan-Calvopina et al.,
2016).
1.6.1 Bulk genome-wide demethylation in PGCs: The early wave

Numerous studies have demonstrated genome-wide demethylation in PGCs from
E7.25 to E13.5. Immunofluorescence staining of 5mC showed that PGCs are globally
demethylated starting as early as E8.0, concomitant with the onset of PGC migration.
Genome-wide profiling confirmed these observations (Guibert et al., 2012; Popp et al.,
2010; Seisenberger et al., 2012a). Demethylation is accompanied by global loss of
H3K9me (Seki et al., 2005), downregulation of DNMT3A (Seki et al., 2005), and
cytoplasmic localization of DNMT3B. DNMT1 is expressed and localized to the nucleus
from E10.5 to E13.5 (Hajkova et al., 2002). In PGCs, Uhrf1 mRNA is also consistently
downregulated after E7.25, and UHRF1 protein expression is undetectable between E8.5
and E11.5 (Ohno et al., 2013), indicating impaired targeting for DNMT1 to the replication
fork (Kurimoto et al., 2008). Passive dilution of DNA methylation was further
demonstrated using hairpin bisulfite sequencing, where strand-specific DNA
methylation can be determined. In PGCs, hemimethylated DNA strands significantly
increased between E10.5 to E11.5 at long-interspersed nuclear elements-1 (LINE1) (Ohno
et al., 2013). Overall, these observations indicate that a variety of mechanisms facilitate
DNA demethylation, including downregulation and nuclear exclusion of de novo and
maintenance DNA methylation machinery and absence of the targeting factors.
Does the oxidation of 5mC by TET proteins contribute to global DNA
demethylation in PGCs? Tet1 and Tet2 mRNA and protein are detectable in PGCs
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between ~E9.5-E12.5. Notably, Tet3 mRNA and protein levels are undetectable,
indicating 5hmC is most likely generated by TET1 and TET2 in PGCs (Hackett et al.,
2013; Hajkova et al., 2010; Yamaguchi et al., 2012). PGCs assayed for 5mC and 5hmC
with mass spectrometry showed increases in 5hmC starting at E8.75 through E12.5.
However, immunostaining did not reveal changes in the levels of 5fC and 5caC,
indicating that further oxidation of 5hmC is not involved in the bulk wave of DNA
demethylation (Hackett et al., 2013; Yamaguchi et al., 2013). Consistently, in
chromosome spreads, 5hmC was only detected on one sister chromatid suggesting that
dilution of the oxidized base through passive replication is responsible for demethylation
in PGCs (Yamaguchi et al., 2013). To determine the role of TET1 catalytic activity on
DNA demethylation in PGCs, an allele without the catalytic domain of TET1 was
generated (Tet1Gt) and methylation was profiled in Tet1Gt E13.5 PGCs. Overall, global
levels of methylation were unchanged, suggesting that TET1 does not contribute to
genome-wide demethylation but may play roles in locus-specific demethylation instead
(Yamaguchi et al., 2012).
It is notable that while overall levels of DNA methylation decrease beginning at
E8.0 in PGCs, and reach a minimum at E13.5, not all parts of the genome follow these
demethylation kinetics. Certain regions are initially resistant to this wave of DNA
methylation, indicating DNA methylation is maintained. These regions include ICRs, a
subset of repetitive elements, and CpG islands on the X-chromosome (Hajkova et al.,
2002; Kobayashi et al., 2013; Seisenberger et al., 2012a). In order for DNA
demethylation resistant loci to maintain DNA methylation, two processes are required.
First, the loci must be resistant to demethylation, possibly through the use of proteins
that protect DNA from demethylation. Second, methylation must be maintained during
cell division. DNMT1, despite the low levels of UHRF1 in PGCs (Seki et al., 2005),
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methylates the H19 ICR, Snrpn ICR, and IAP elements. This suggests that DNMT1 can
localize to specific regions including IAPs and ICRs to maintain DNA methylation
(Hargan-Calvopina et al., 2016).
1.6.2 Chromatin Landscape Dynamics during DNA Demethylation in PGCs

During DNA demethylation in PGCs, conflicting reports describe changes in the
chromatin landscape. It is generally agreed that early PGCs are characterized by global
depletion of H3K9me2, and enrichment in H3K27me3, H3K4me2/3, H3K9ac, and
H4/H2AR3me2s as determined by immunofluorescence staining (Ancelin et al., 2006;
Hajkova et al., 2008; Seki et al., 2005). However, one study found that by E11.5, the loss
of the linker histone, H1, as well as the loss of many heterochromatin marks such as
H3K9me3, H3K27me3, and HP1 coincided with a loosening of the overall chromatin
structure and enlarged size of the nucleus. H3K9ac marks are also lost at this time point
(Hajkova et al., 2008). Conversely, another study reported that at E11.5, there was no
loss of the linker histone, no loss of chromocenters, and no loss of H3K27me3 (Kagiwada
et al., 2013). These conflicting reports may be due to the use of small numbers of single
cell suspensions of PGCs compared to quantification using whole-mount
immunofluorescence in the second study (Kagiwada et al., 2013). Hajkova et al. reports
that at E12.5, PGCs have regained bright DAPI-staining chromocenters, H1, H3K9me3,
and slowly start to accumulated H3K27me3. The enzyme complex of BLIMP1-PRMT5
responsible for adding H4/H2AR3me2s is excluded from the nucleus at this time and
this coincides with the loss of these marks (Ancelin et al., 2006). While the exact levels of
different histone modifications during PGC reprogramming are not yet completely clear,
these dynamic changes in chromatin modifications may be interrelated with the
concurrent DNA demethylation and may be necessary for PGC reprogramming.
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1.6.3 ICR demethylation in PGCs

As stated above, ICRs retain their methylation in PGCs until approximately E10.5
and then are demethylated in a gene-specific stereotypical pattern. This result was first
demonstrated by assaying DNA methylation at individual imprinted genes. Early
profiling studies in F1 hybrid mice demonstrated that the H19 ICR was considerably
demethylated on both the maternal and paternal allele by E13.5 in PGCs (Davis et al.,
2000). Lee et al. generated embryos from PGC clones and used the imprinting status of
these embryos as proxies for the imprinted status in the parental PGCs. ICRs in embryos
derived from E11.5 PGCs had very different levels of methylation, indicating this
demethylation of ICRs occurs somewhat stochastically across a population of PGCs. This
result also suggested that each ICR had its own demethylation timing: the Nnat ICR was
one of the earliest to demethylate, the H19 ICR was “intermediate”, whereas the Peg10
ICR was the slowest and thus the most resistant to DNA demethylation. The timing of
DNA methylation in PGCs and PGC clones had good concordance (Lee et al., 2002).
Additionally, locus-specific bisulfite sequencing of PGCs revealed that the Peg3, Lit1,
Snrpn, and H19 ICRs were demethylated between E11.5 to E12.5 and this demethylation
persisted until E13.5 (Hajkova et al., 2002). Sato and colleagues sorted GFP transgenic
PGCs and found Igf2r ICR methylation at E10.5, but demethylation initiated at E11.5
(Sato et al., 2003).
Simultaneous profiling of all ICR methylation in smaller cell numbers was greatly
enhanced by whole-genome bisulfite sequencing. Using this technique, at E10.5, ICRs
were approximately 40% methylated. At E13.5, in both males and female PGCs, none of
the paternally methylated ICRs showed appreciable DNA methylation, confirming the
results from earlier locus-specific approaches (Kobayashi et al., 2013). Hackett et al. also
found that demethylation timing depended on the imprinted gene in question. Whereas
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Peg10 and Peg3 ICRs were slow to demethylate, Igf2r ICR and the KvDMR exhibited
faster demethylation kinetics (Hackett et al., 2013). Thus, how long DNA methylation is
retained depends on the ICR. Interestingly, despite locus specific timing of DNA
demethylation at ICRs, chromatin accessibility from E11.5 to E13.5 in both male and
female PCGs was found to be relatively constant at ICRs (Guo et al., 2017).
1.6.4 Repetitive Elements

Certain classes of repetitive elements are also resistant to DNA demethylation.
For example, sequences retaining the highest levels of DNA methylation in PGCs at E13.5
include certain families of long terminal repeats (LTR) endogenous retroviruses. IAPs
are partially demethylated by E12.5 but are not further demethylated by E13.5 (Crichton
et al., 2014). While some partial resistance to DNA demethylation has been reported for
LINE elements (Hajkova et al., 2002; Kobayashi et al., 2013), both LINES and short
interspersed nuclear elements (SINEs) are considered to be largely reprogrammed in the
germline (Seisenberger et al., 2012a). Lastly, resistance to demethylation appears
dependent upon CpG density (Kobayashi et al., 2013).
1.6.5 TET-mediated demethylation of ICRs in the second wave of PGC demethylation

The second wave of demethylation includes ICR demethylation. The expression
of TET1 and TET2 in PGCs prompted investigators to examine whether these enzymes
participate in ICR demethylation. Multiple lines of evidence were consistent with this
idea. Fusion of embryonic germ cells derived from E12.5 PGCs with B cells resulted in
ICR demethylation, which coincided with a rapid accumulation of 5hmC (Piccolo et al.,
2013). Tet1 depletion using short-hairpin RNA interference in this system caused a loss
of 5hmC accumulation at the H19 ICR, and the failure to demethylate, despite the
presence of TET2 (Piccolo et al., 2013). Physiological experiments directly showed a role
for TETs in ICR demethylation. Using glucosyltransferase-quantitative polymerase chain
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reaction (Glu-qPCR) to measure locus-specific 5hmC, levels of DNA methylation loss
correlated with 5hmC gains at the KvDMR, Peg10, Igf2r, and Peg3 ICRs in PGCs
(Hackett et al., 2013). 9.5 and 10.5 day embryos generated from a homozygous Tet1Gt
mouse mated to wild-type mouse (Yamaguchi et al., 2012), or from 13.5 day embryos
generated from Tet1;Tet2 double knockout mice mated to either Tet1;Tet2 double
heterozygous mice or to wild-type mice (Dawlaty et al., 2013) showed hypermethylation
at ICRs as well as dysregulated total levels of imprinted gene expression (Tables 1.1 and
1.2) (Dawlaty et al., 2013; Yamaguchi et al., 2013). Together, evidence strongly suggests
that TET1 may be a prominent mediator of ICR erasure. Work in this thesis further
addresses the role of TET1 in mediating genomic imprinting (see Chapter 2).
Despite the accumulation of 5hmC in wild-type PGCs, dependent upon the
catalytic activity of at least TET1, the further processing of this oxidized base may occur
by replication-dependent dilution. Multiple studies report a decrease in 5hmC levels to
be consistent with the predicted replication rate of PGCs (Hackett et al., 2013; Kagiwada
et al., 2013). Indeed, levels of Tdg mRNA, the protein responsible for cleaving 5fC and
5caC from the genome, drop from E9.5 to E13.5 in PGCs (Kagiwada et al., 2013).
Therefore, evidence for active processing of 5hmC at ICRs is still wanting.

1.7 Reacquisition of DNA Methylation at ICRs
Once PGCs have completed demethylation at E13.5, genome-wide and locusspecific remethylation initiates. This remethylation is essential for ICRs to acquire their
parental-specific imprints during germ cell development. Male germ cells acquire DNA
methylation at ICRs shortly after DNA demethylation ceases, and DNA methylation is
completed mostly before birth. In contrast, maternal specific-imprints are acquired
predominantly after birth during oocyte growth (Lucifero et al., 2004; Stewart et al.,
2016).
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While our understanding of how ICRs are targeted for remethylation in the
developing germ cells is incomplete, well-validated observations have been made. First,
DNA methylation imprints are acquired when the histone modifications H3K4me2/3 are
low, levels of the histone demethylases KDM1A and KDM1B are high, and H3K36me3 is
high (Gahurova et al., 2017). Additionally, transcription likely plays a major role in the
timing of imprinting acquisition, although transcription is not sufficient to explain this
timing (Henckel et al., 2011; Stewart et al., 2015; Stewart et al., 2016). A unique case is
found at the Rasgrf1 imprinted locus where piwi-interacting RNAs (piRNAs) have been
proposed to play a role in DNA methylation establishment in the male germline
(Watanabe et al., 2011). While DNMT3B, DNMT3A, and DNMT3L are required for
methylating the Rasgrf1 ICR, other ICRs, such as the H19 and Igf2r ICRs, are targeted
by DNMT3A and DNMT3L (Tables 1.1 and 1.2) (Stewart et al., 2016). Interestingly, the
timing of acquisition of imprinted marks is not the same on the previously paternal and
previously maternal alleles, indicating a non-equivalence of the underlying chromatin
state, despite the lack of DNA methylation in PGCs (Davis et al., 2000; Lucifero et al.,
2004). Thus, a complex interplay between DNA methylation regulators, chromatin
regulators, transcription, and long-noncoding RNAs together function in a complex
manner to methylate the regions crucial for imprinted expression in the next generation.

1.8 Beyond Epigenetic Reprogramming: Other Roles of 5hmC
5hmC is the second most abundant modified cytosine residue in DNA, ranging
from 0.03%-0.7% of all cytosine bases in the genome, with the highest levels being
present in the central nervous system (Globisch et al., 2010). Given the moderately high
levels of this base, as well as tissue-specific levels and distribution, 5hmC has been
proposed to be not just an intermediate of DNA demethylation, but perhaps a stable
epigenetic mark in its own right (Guo et al., 2014b; Hahn et al., 2013; Hahn et al., 2014;
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Nestor et al., 2012). In ESCs, 5hmC tends to be enriched across gene bodies, CpG-rich
promoters, and distal regulatory elements. (Pastor et al., 2011; Williams et al., 2011; Wu
et al., 2011b). Using Tet1 and Tet2 knockdown in ESCs, Huang et al. found that regions
that lost 5hmC upon Tet1 knockdown tended to be in promoters and that 5hmC in this
region were negatively correlated with gene expression. In contrast, gene bodies tended
to lose 5hmC upon Tet2 knockdown, and this enrichment in gene bodies was positively
correlated with gene expression (Huang et al., 2014). 5hmC, unlike 5mC, is not enriched
in repetitive elements such as IAPs and minor satellite repeats (Williams et al., 2011).
Lastly, in HEK293T cells, overexpression of full-length TET1 was found to decrease 5mC
in sparsely methylated CGIs (1-10% 5mC) but not in regions with higher 5mC.
Additionally, the increase in 5hmC specifically at the border of unmethylated CGIs led to
the idea that 5hmC may protect CGIs from encroachment of DNA methylation (Jin et al.,
2014; Williams et al., 2012). Taken together, depending on the cell type, which TET
family members are expressed, and the particular genomic region in question, 5hmC
may play roles in transcription and DNA methylation maintenance.

1.9 Summary
The discovery of the TET family of proteins has greatly expanded our
understanding of crucial epigenetic processes, including epigenetic reprogramming. This
dissertation aims to elucidate the role that TET1 plays specifically in the reprogramming
of ICRs. Chapter two provides valuable additional details into the erasure of both male
and female imprints in the germline and how this erasure affects the monoallelic
expression of imprinted genes in subsequent generations. Lastly, chapter three will detail
ongoing and future work to answer remaining questions regarding TET1 and its role in
genomic imprinting.
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1.10 Contributions
This chapter contains direct quotes and figures from SanMiguel and Bartolomei et al.
published in 2018 in Biology of Reproduction (SanMiguel and Bartolomei, 2018).
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Figure 1.1. Schematic of the H19 imprinted locus in mice. Arrows show
enhancer activation of transcription. The blunt-ended arrow indicates the enhancerblocker function of the insulator formed by the CTCF-bound unmethylated maternal
ICR. The details of imprinted regulation at this locus are provided in the text.
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Figure 1.2. The life cycle of a DNA methylation imprint. ICRs obtain their
parent-of origin-specific DNA methylation in the haploid genomes of germ cells. This
differential methylation is maintained through fertilization. In contrast, secondary
DMRs acquire DNA methylation after fertilization. PGCs are specified from the epiblast
and thus need to erase imprinted methylation as PGCs develop, allowing a ground state
for the acquisition of imprinted methylation in the germline.
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Table 1.1. Genetic models of imprinted expression and DNA methylation regulators at the H19 locus in mice
H19 ICR DNA
Genotype
Tissue
Allelic Expression
Reference
Methylation
H19
biallelic;
Igf2
Dnmt1n/n (hypomorph)
E10.5 embryos
ND
(Li et al., 1993b)
repressed
Dnmt1s/s (replication
(Caspary et al.,
foci targeting domain
E9.5 concepti
H19 biallelic
ND
1998)
mutation)
H19
biallelic;
Igf2
Dnmt1n/n
E9.5 concepti
ND
repressed
(Weaver et al.,
Dnmt1+/n
E9.5 concepti
*H19 biallelic
ND
2010)
Dnmt1+/c (c = null)

E9.5 concepti

H19 =

ND

Dnmt1mat-/+

E3.5 blastocysts

ND

*H19 ↓

Dnmt1mat-/-

E3.5 blastocysts

ND

H19 ↓

Uhrf1-/-

ESCs
E9.5 embryos

ND
H19 biallelic; Igf2
repressed

H19 ↓

Uhrf1-/Dnmt3amat-/-; Dnmt3b+/-

E9.5 embryos

ND

H19 =

Dnmt3a2lox/1lox, TNAP–Cre x
WT male (maternal
deletion only)

E10.5 embryos

ND

H19 =

Dnmt3a2lox/1lox, TNAP–Cre -/males

Spermatogonia
(P11 Testis)

ND

H19 ↓

Paternal germline
deletion Dnmt3b
Maternal germline
deletion Dnmt3b
Dnmt3a-/-; Dnmt3b-/DKO (Maternal-zygotic
null)

Pups#

ND

H19 =

Pups#

ND

H19 =

E9.5 embryos

H19 =

H19 =

(Hirasawa et al.,
2008)

Dnmt3l-/-

Spermatogonia
(P11 Testis)

ND

H19 ↓

(Kaneda et al.,
2004)

Dnmt3l-/-

ESCs

ND

Igf2 DMR2 ↓

Dnmt3lmat-/-

E9.5 embryos

ND

H19 =

(Hata et al.,
2002)

Dnmt3lmat-/+

Embryos#

H19 =; Igf2 =

H19 =

Dppa3mat-/+

PN5 zygotes

ND

H19 ↓

Dppa3-/-

E12.5 PGCs

ND

H19 =

ND

H19 =

ND

H19 =

ND

(Hirasawa et al.,
2008)
(Sharif et al.,
2007)
(Hata et al.,
2002)

(Kaneda et al.,
2004)

(Bourc’his et al.,
2001)
(Nakamura et
al., 2007)
(Nakashima et
al., 2013)

Zfp57mat-/- (maternalzygotic)
Zfp57+/-

E11.5-E13.5
embryos
E11.5-E13.5
embryos
Sperm

ND

H19 =

Zfp57-/-

Sperm

ND

H19 =

Trim28chatwo/chatwo
(zygotic hypomorph)

E8.5 embryos

*H19 biallelic; Igf2
repressed

*H19 ↓

Trim28L-/L- (zygotic null)

E7.5 embryos

Igf2 repressed

*H19 ↓

E7.5 embryos

H19 biallelic

ND

8-cell stage
embryos

ND

*H19 ↓

(Lorthongpanich
et al., 2013)

E12.5 embryos

ND

*H19 ↓; * H19
secondary DMR ↓

(Messerschmidt
et al., 2012)

Zfp57-/- (zygotic only)

Hypomorphic maternalzygotic Trim28
Trim28mat-/+ (maternal
null)
Trim28mat-/+ (maternal
null)
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(Li et al., 2008)

(Alexander et
al., 2015)

[Tet1-/-;Tet2-/-] female x
WT male
[Tet1-/+;Tet2-/+]

female x
[Tet1-/-;Tet2-/-] male

E4.5 embryos

ND

*H19 ↓

P1-2 pups

ND

*H19 ↑

P1-2 pups

ND

*H19 ↑

(Dawlaty et al.,
2013)

Table Key: *(partially penetrant); ND (no data); = (no change); ↓ (hypomethylated); ↑ (hypermethylated); # (age
not explicitly stated) P (postnatal day); PN (Pronuclear stage); ESCs (Embryonic stem cells); PGCs (primordial
germ cells)
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Table 1.2. Genetic models of imprinted expression and DNA methylation regulators at the Igf2r locus in mice
Igf2r ICR DNA
Genotype
Tissue
Allelic Expression
Reference
Methylation
n/n
Dnmt1 (hypomorph)
E10.5 embryos
Igf2r =
*Igf2r ↓
Dnmt1s/s (replication foci
targeting domain
mutation)

E9.5 embryos

Igf2r repressed

ND

Dnmtn/c (c = null)

E9.5 embryos

Igf2r repressed

Igf2r ↓

Dnmt3amat-/-;Dnmt3b+/-

E9.5 embryos

ND

Igf2r ↓

(Hata et al.,
2002)

Dnmt3a2lox/1lox, TNAP–Cre x
WT male (maternal
deletion only)

E10.5 embryos

Igf2r repressed

Igf2r ↓

(Kaneda et al.,
2004)

Dnmt3l-/-

ESCs

ND

Igf2r =

Dnmt3lmat-/-

E9.5 embryos

ND

Igf2r ↓

(Hata et al.,
2002)

Zfp57mat-/- (maternalzygotic)

E11.5-E13.5 embryos

ND

* Igf2r ↓

Zfp57-/- (zygotic null)

E11.5-E13.5 embryos

ND

* Igf2r ↓

Zfp57+/-

Oocytes

ND

* Igf2r ↓

Zfp57-/-

Oocytes

ND

* Igf2r ↓

Trim28chatwo/chatwo (zygotic
hypomorph)

E8.5 embryos

* Airn biallelic

ND

(Alexander et al.,
2015)

Trim28mat-/+ (maternal
null)

8-cell stage embryos

ND

* Igf2r ↓

(Lorthongpanich
et al., 2013)

Tet1Gt/Gt (catalytic
domain removed)

E9.5 embryos

* Airn repressed

* Igf2r ↑

(Yamaguchi et
al., 2013)

(Li et al., 1993b)

(Li et al., 2008)

Table Key: *(partially penetrant); ND (no data); = (no change); ↓ (hypomethylated); ↑ (hypermethylated); # (age not
explicitly stated) P (postnatal day); PN (Pronuclear stage); ESCs (Embryonic stem cells); PGCs (primordial germ
cells)
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CHAPTER 2: IMPRINTED GENE DYSREGULATION IN A TET1 NULL
MOUSE MODEL IS STOCHASTIC AND VARIABLE IN THE
GERMLINE AND OFFSPRING
2.1 Introduction
Epigenetic reprogramming of ICRs in the germline is critical to the appropriate
regulation of imprinted genes in offspring. Imprinted genes are uniquely expressed from
only one parental allele and play important roles in growth and development
(Plasschaert and Bartolomei, 2014). ICRs have DNA methylation on one parental
chromosome that controls the monoallelic, parent-of-origin-specific expression of
imprinted genes. By E13.5, ICRs are completely demethylated in the germline, which is
necessary to allow the acquisition of the parent-of-origin specific DNA methylation
patterns, either at maternally-methylated ICRs in the developing oocytes, or at
paternally-methylated ICRs in the developing sperm (Stewart et al., 2016). This
asymmetric DNA methylation of ICRs ensures proper monoallelic expression of
imprinted genes in the resultant embryo.
The observation that DNA methylation at ICRs is resistant to the initial phase of
demethylation in PGCs is consistent with ICR erasure being an active process. The
discovery of the Ten-Eleven Translocation (TET) family of enzymes, TET1, TET2, and
TET3, (Tahiliani et al., 2009) implicated their potential relevance to ICR DNA
methylation erasure (Hill et al., 2014). All three TETs have the ability to progressively
oxidize the methyl group on cytosines (5mC) to 5-hydroxymethylcytosine (5hmC), 5formylcytosine (5fC), and 5-carboxylcytosine (5caC) (Ito et al., 2011; Tahiliani et al.,
2009). This iterative oxidation is thought to play an active part in removing DNA
methylation in conjunction with replication or base excision repair (Hajkova et al.,
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2010). In PGCs, Tet1 is the most highly expressed family member, while Tet2 is
expressed at a lower level, and Tet3 is undetectable (Hackett et al., 2013; Hajkova et al.,
2010; Kagiwada et al., 2013; Yamaguchi et al., 2012). Previous studies showed abnormal
levels of DNA methylation and abnormal levels of total expression of imprinted genes in
Tet1-/- single and Tet1-/-; Tet2-/- double knockout mice (Dawlaty et al., 2013; Yamaguchi
et al., 2013). However, most experiments in the Yamaguchi et al., 2013 study used a Tet1
allele in which a fusion protein was generated. The catalytic domain of the endogenous
TET1 protein was replaced with a b-galactosidase cassette, but the DNA-binding CxxC
domain was retained (Yamaguchi et al., 2012). This study also focused primarily on the
effects of Tet1 on ICR methylation in the male germline. Additionally, the Tet1-/-; Tet2-/mouse model did not allow the elucidation of the precise contribution of Tet1 to ICR
DNA methylation regulation (Dawlaty et al., 2013). Thus, our understanding of the role
of Tet1 in the regulation of genomic imprinting is incomplete. The goal of our study is to
define the function of Tet1 in both male and female germ cells using a null allele of Tet1
in mice. Furthermore, we aim to elucidate how loss of Tet1 affects the monoallelic
expression of imprinted genes by studying offspring of male and female Tet1 knockout
animals. In addition to its requirement in the male germline, our work demonstrates for
the first time, that Tet1 is required for normal ICR methylation in female germ cells.
Moreover, lack of Tet1 in the germline leads to stochastic biallelic expression of
imprinted genes across different stages of development in offspring. Importantly, we
show that the reliance of TET1-mediated demethylation varies according to the
imprinted locus, suggesting a complex relationship between TET1 demethylation and
genomic context.
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2.2 Results
2.2.1 Loss of Tet1 leads to stochastic and variable DNA hypermethylation at ICRs in
oocytes.

To examine how loss of Tet1 affects DNA methylation (mCpG) in the female
germline, we collected germinal vesicle stage oocytes from 3.5-week-old mice generated
by mating heterozygous Tet1 mutant mice. One pool of oocytes per mouse was bisulfite
treated and ICR mCpG levels were subsequently analyzed by pyrosequencing (Fig. 2.1A).
We investigated two of the three known paternally methylated ICRs in the mouse
genome: H19/Igf2 and IG-DMR. As expected, Tet1 wild-type (WT) and heterozygous
(Het) pools of oocytes had very low levels of mCpG at the H19/Igf2 ICR and the IG-DMR
while the maternally methylated Peg3 ICR was nearly completely methylated and served
as an internal control for somatic contamination. In contrast, Tet1-/- (KO) oocyte pools
showed stochastic hypermethylation at both the H19/Igf2 and the IG-DMR, meaning
some KO oocyte pools had mCpG levels comparable to WT and Het pools, while other
KO oocyte pools had increased levels of mCpG (Fig 2.1B). The stochastic nature of the
DNA methylation abnormalities was reflected in bimodal distributions in KO oocyte
pools at each of the two paternally methylated ICRs (Fig. S2.1A,B). Affected KO oocyte
pools were also variable in the severity of the hypermethylation phenotype, with each
oocyte pool exhibiting different levels of abnormal mCpG, particularly at the IG-DMR
(Fig. 2.1B and Table S2.1). Additionally, the variance in mCpG was significantly higher in
the KO oocytes at H19/Igf2 ICR and IG-DMR compared to controls (WT vs KO: p =
0.008, p = 0.026, respectively), whereas there was no difference in mCpG levels and
variance at the Peg3 ICR (Fig. 2.1C). Moreover, there was no correlation between
abnormal methylation at IG-DMR and H19/Igf2 in KO oocyte pools (Fig. S2.1C). Thus,
consistent with the hypothesis that Tet1 is required for proper DNA demethylation of
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ICRs, lack of Tet1 in the female germline leads to stochastic hypermethylation and
significant increases in DNA methylation variance at paternally methylated ICRs.
2.2.2 Loss of Tet1 leads to biallelic expression and changes in DNA methylation of
imprinted genes in the offspring of female KO mice.

We speculated that the abnormalities in oocyte methylation might cause
developmental defects in the resultant offspring. To address this question, we crossed
either Tet1 Het or KO females to WT Tet1 males on the C57BL/6J(CAST7) (C7)
background, which have a Mus musculus castaneus chromosome 7 on a C57BL/6J (B6)
background (Fig. S2.2A,B). These F1 hybrid animals harbor SNPs on chromosome 7 that
allow the parental origin of the RNA to be determined. Het Tet1 females crossed to C7
males are hereafter referred to as mCON, and their offspring are either heterozygous or
wild-type for Tet1. mKO refers to Tet1 KO females crossed to C7 males. mKO offspring
are all heterozygous for Tet1. We analyzed the number of live and resorbed embryos and
placentas at E10.5 from mCON and mKO matings. By this developmental stage, there
was a significant decrease in live embryos (p = 0.005) and a significant increase in
resorbed embryos (p = 0.011) in mKO litters compared to mCON litters (Fig. 2.2A,B).
This result indicates that offspring derived from Tet1 KO females are more susceptible to
fetal demise than those derived from mCON females at E10.5.
Next, we asked whether abnormal ICR methylation in the germline could affect
the allele-specific expression of imprinted genes in the offspring of female Tet1 KO mice.
Given that each inherited Tet1-/- parental allele contributing to an ICR in the offspring
has a 50% chance of being unmethylated (previously maternal) or methylated
(previously paternal and failed to erase in the germline), a priori we expect that the
number of affected offspring would be 50%. Using restriction fragment length
polymorphism analysis (RFLP), we quantified allele-specific expression at the H19/Igf2
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locus (Fig. 2.2C and Table S2.2). Three mKO-derived embryos from independent litters
exhibited biallelic expression of Igf2 (3/36) whereas none of the mCON-derived embryos
were affected (0/34) (Fig. 2.2D). This result shows the imprinting phenotype was neither
present in every mKO embryo nor at the expected proportion of 50%. Additionally, in an
affected conceptus, Igf2 expression was biallelic in both the embryo and its placenta
(Table S2.2).
To address how mCpG levels at the ICR may correspond to abnormal imprinted
gene expression, we analyzed mCpG via pyrosequencing. We found that the mKO
embryos with biallelic Igf2 expression also showed DNA hypermethylation at the ICR
(Fig. 2.2E). Additionally, we measured total expression of the imprinted genes Igf2 and
H19. Given hypermethylation of the ICR, the three biallelic mKO embryos had
undetectable levels of H19 expression, as expected. Igf2 expression was less predictable
but reflected increased total expression in the embryos that expressed Igf2 biallelically
and were hypermethylated at the H19/Igf2 ICR. (Fig. 2.2F). As expected, H19 expression
in both mCON and mKO embryos and placentas was monoallelic or not expressed (Fig
2.2F, Table S2.2). Of note, two of the three affected embryos were female (Tables
S2.2,S2.3). Together, these results indicate that H19/Igf2 ICR hypermethylated oocytes
can contribute to live embryos that have abnormal allele-specific expression of Igf2,
which is associated with hypermethylation at the ICR.
We next determined if the mCpG and total expression patterns observed at the
H19/Igf2 locus were similar at the paternally methylated IG-DMR (Fig. 2.3A). There was
a significant increase in proportion of hypermethylated E10.5 mKO embryos at the IGDMR compared to mCON embryos (10/36 vs. 1/34, respectively, p = 0.007) (Fig. 2.3B).
ICR hypermethylation was stochastic as not every KO embryo was affected and this
proportion deviated from the expected 50%. Only one mKO embryo had
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hypermethylation at both H19/Igf2 and the IG-DMR (1/29, embryo “A”, see Figs 2.2C &
2.3B), whereas the rest of the affected embryos were hypermethylated at a single locus.
This result reflects a lack of correlation between hypermethylation of the two loci in any
given mKO animal.
Although we could not investigate allele-specific expression in our F1 hybrid
model because the IG-DMR is on chromosome 12, we were able to measure total
expression. Embryos that had abnormal hypermethylation at IG-DMR also had silenced
Meg3 expression, as expected given that IG-DMR methylation silences Meg3 expression
(Lin et al., 2003). Similar to Igf2 total expression, however, total levels of Dlk1 were
variable, ranging from wild type levels of expression to 2.5-fold increases in expression
compared to controls (Fig. 2.3C). Of 36 mKO offspring, 12 showed imprinting defects at
the H19/Igf2 locus, the IG-DMR locus, or both. Of these 12 affected offspring, nine were
females and three were males, indicating a significant sex-biased effect early in
development (p = 0.033, Table S2.3) despite the expected Mendelian ratio of male and
female embryos. Thus, Tet1 in the maternal germline is also required for proper IG-DMR
mCpG levels in offspring and may preferentially affect female offspring.
To determine if the abnormalities we observed at the H19/Igf2 ICR during
embryogenesis were also present at birth, we isolated tissues from mKO and mCON pups
at postnatal day (P)0 and measured allele-specific expression and mCpG levels. While
the average number of mKO live-born pups was lower than mCON pups, this difference
was not significant (p = 0.067) (Fig 4A). mCON tissues showed no biallelic expression
(0/16). However, we observed biallelic expression of Igf2 in mKO pups (2/31) and this
change was consistent between tissues (tongue and liver, Fig. 2.4B). These affected pups
were female (Tables S2.3,S2.4). There was no significant difference between the
proportion of P0 mKO pups with biallelic Igf2 compared to the proportion of E10.5 mKO
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embryos with biallelic Igf2 (p = 1.00), indicating these changes are present at the same
frequency from mid-gestation through birth.
2.2.3 Loss of Tet1 leads to stochastic DNA hypermethylation at ICRs in sperm.

Next, we addressed the effects of Tet1 deletion on the male germline. We
collected motile sperm from Tet1 WT, Het, and KO adult males for mCpG analysis by
pyrosequencing (Fig. 2.5A). WT and Het sperm showed the expected low levels of mCpG
at the maternally methylated KvDMR, Peg3, Snrpn, and Peg1 ICRs. The paternally
methylated ICRs, H19/Igf2 and IG-DMR, had the expected hypermethylation in sperm
regardless of the paternal genotype. In contrast, mCpG levels were significantly
increased at the KvDMR, Peg1, and Peg3 ICRs in KO samples (WT vs KO, p < 0.0001, p
= 0.002, p = 0.003, respectively). The Snrpn ICR had neither significant
hypermethylation nor had significant differences in variance (WT vs KO, p = 0.112, p =
0.91, respectively) (Fig 2.5B). The pyrosequencing results were confirmed by bisulfite
mutagenesis, followed by cloning and sequencing for the H19/Igf2 and Peg3 ICRs (Fig.
S2.3A,B). Because the Snrpn ICR was demethylated in the Tet1 KO sperm, we
hypothesized that another protein, such as TET2, or a different demethylation pathway
could be compensating in the absence of TET1. To test this hypothesis, we examined
sperm from Tet1/Tet2 double knockout mice (DKO) and saw no significant difference in
DNA methylation level between KO and DKO sperm (Table S2.5), indicating TET1 is the
primary enzyme responsible for DNA methylation imprint erasure at KvDMR, Peg1, and
Peg3 ICRs but TET1 and TET2 are dispensable for the erasure of the Snrpn ICR.
2.2.4 Loss of Tet1 leads to biallelic expression and changes in DNA methylation of
imprinted genes in the offspring of male KO mice.

We next asked how hypermethylated sperm affected allele-specific expression of
imprinted genes and mCpG levels at ICRs in the offspring of Tet1 KO male mice. Because
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abnormal methylation at maternally methylated ICRs is thought to be less detrimental to
normal development (Kawahara et al., 2007), we hypothesized that changes comparable
to maternal Tet1 deficiency would be observed at a slightly later time in gestation in
paternal KO. Therefore, to collect F1 hybrid tissues for analysis, we mated Tet1 Het or
KO males with Tet1 WT females on the C7 background to generate E12.5 paternal control
offspring (pCON) or paternal KO offspring (pKO) (Fig. S2.2C,D). At E12.5, there were
significantly fewer live pups (p =0.019) and significantly more resorbed and delayed
pups in the pKO offspring (p = 0.011) compared to pCON offspring (Fig. 2.6A,B).
We then examined changes in allele-specific expression at the KvDMR in E12.5 pCON
and pKO embryos (Fig. 2.6C). pKO embryos were more likely to express Cdkn1c
biallelically (7/29) than pCON embryos (1/24) (Fig. 2.6D). Embryos with biallelic Cdkn1c
expression exhibited DNA hypermethylation at the KvDMR (Fig. 2.6E). Notably,
stochastic DNA hypermethylation of the Peg3 ICR was also observed amongst pKO
offspring (Table S2.6), but no single embryo had both Peg3 and KvDMR
hypermethylation (Fig. S2.4A). Because these loci are on opposite ends of chromosome
7, this result suggests meiotic recombination may dictate which pups within a litter are
affected. The changes in allele-specific expression and DNA methylation were also
observed in the corresponding placentas (Fig. S2.5 and Table S2.6). Unlike what was
observed in the maternal offspring, male and female embryos from pKO crosses were
equally affected (p = 0.665, Tables S2.3,S2.6).
Lastly, to determine if changes in allele-specific expression and mCpG levels at
maternally methylated ICRs are detected at birth, we measured imprinted gene
expression by RFLP and mCpG levels by pyrosequencing analysis in tissues from pCON
and pKO P0 pups. pCON pups exhibited proper monoallelic expression of Cdkn1c while
pKO pups had biallelic Cdkn1c expression (3/29) (Fig. 2.7A and Table S2.7). The pups
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with biallelic expression also had hypermethylation at the KvDMR, which was consistent
across three tissue types (Fig. 2.7B and Table S2.7). Similar to what was observed at
E12.5, litter sizes at P0 were significantly smaller in the pKO litters compared to pCON
litters at birth (p < 0.0001) (Fig. 2.7C). This result suggests that embryonic lethality may
contribute to a smaller proportion of affected animals at P0 compared to E12.5. Lastly, as
observed at E12.5, we also noted mutually exclusive hypermethylation of the Peg3 ICR
and the KvDMR (Fig. S2.4B). Together, these data show that the sperm
hypermethylation in male KO animals was transmitted to a subset of offspring, resulting
in defects in imprinted gene expression and ICR methylation.

2.3 Discussion
In the developing germline, DNA methylation at ICRs must be erased so that
parent-of-origin specific imprints can be established according to the sex of the embryo.
These sex-specific DNA methylation patterns are necessary for proper imprinted gene
expression in the offspring. The importance of this process is highlighted in human
imprinting disorders, where loss of imprinted gene expression or changes in DNA
methylation at ICRs can lead to disorders such as Beckwith-Wiedemann, Angelman, and
Prader Willi syndromes (Kalish et al., 2014). While DNA methylation at the global level
has been well-studied (Guibert et al., 2012; Hajkova et al., 2002; Kagiwada et al., 2013;
Seisenberger et al., 2012a; Seki et al., 2005), how imprints are effectively removed to
allow imprinted gene expression in subsequent generations remains elusive. Only
recently were the TET family of proteins discovered (Tahiliani et al., 2009).
Subsequently, TET1, the predominantly expressed TET family member in PGCs, has
been implicated in the ICR DNA demethylation process (Dawlaty et al., 2013; Yamaguchi
et al., 2013). Until now, the role of TET1 in genomic imprinting was poorly understood,
given the paucity of data involving the female germline and lock of allele-specific
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expression analysis in the offspring. Here, we used a Tet1 null allele to systematically
investigate the function of TET1 in DNA demethylation of ICRs in both the maternal and
paternal germlines. Furthermore, we determined the effect of Tet1 loss on imprinted
gene expression in the offspring of maternal and paternal Tet1 KO mice.
We found variable levels of DNA methylation among Tet1 KO oocyte pools
collected from different females at the paternally methylated ICRs, H19/Igf2 and IGDMR. This variability could be attributed to a few different factors. First, because germ
cells are derived from the diploid epiblast, each parental allele has an equal chance of
being represented in the gamete. Thus, we expect two distinct populations within a pool
of oocytes from a given Tet1 KO female mouse. An allele originally derived from the
unmethylated maternal allele will remain unmethylated and thus contribute with no
apparent defect to subsequent offspring. However, an allele that was originally paternal
and methylated may fail to erase in the absence of TET1, in which case, these oocytes will
be hypermethylated. Therefore, the theoretical maximum DNA methylation level in a
bulk pool of oocytes from one mouse will be 50%. However, meiotic defects have been
reported in a gene-trap allele of Tet1; these defects were linked to increased levels of
oocyte apoptosis during prophase I of meiosis (Yamaguchi et al., 2012). Consistent with
this observation, we observe variable levels of hypermethylated oocytes at the paternally
methylated ICRs. This hypermethylation includes deviations from the expected 50%
levels of DNA methylation, including levels higher than 50%, which can be explained by
stochastic oocyte apoptosis. Consistent with variable oocyte apoptosis, we see bimodal
distributions of DNA methylation across analyzed oocyte pools (Fig S2.1A, B). Secondly,
it is possible that loss of TET1 could affect PGC migration and/or proliferation timing. A
number of genes have been reported to affect PGC proliferation and/or migration in a
cell-autonomous manner (Saitou and Yamaji, 2012). Lack of Tet1 may directly or
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indirectly affect expression of these genes and thus affect the timing or migration
patterns of PGCs. If a particular PGC can divide more frequently than another PGC, or is
delayed in reaching the gonad where proliferation ceases, these PGCs would lose more
DNA methylation due to replication in the absence of DNA methylation machinery than
a PGC that divides more slowly or migrates to the gonad faster. Notably, TET1 binds to
the Dazl promoter in ESCs (Williams et al., 2011), a critical factor in PGC development,
survival, and differentiation (Haston et al., 2009; Lin and Page, 2005; Ruggiu et al.,
1997; Schrans-Stassen et al., 2001). Dazl expression has also been demonstrated to be
regulated by promoter methylation, and is hypermethylated in a PGC-like cell model
where both Tet1 and Tet2 are simultaneously knocked down (Hackett et al., 2013).
Lastly, we also see differences in the levels of hypermethylation between H19/Igf2 and
IG-DMR (Fig. 2.1). This result further emphasizes that a number of the aforementioned
factors may be contributing to the variability at these loci.
We additionally identified ICR hypermethylation alterations in the offspring of
female Tet1 KO mice. Notably, the proportion of affected E10.5 mKO embryos mirrors
the relative percent hypermethylation of each ICR in the oocytes. The presence of these
abnormalities in both oocytes and E10.5 embryos suggests that abnormalities
established in the germline are maintained throughout fertilization and the early
epigenetic reprogramming of the preimplantation embryo. Furthermore, offspring with
hypermethylation of the H19/Igf2 ICR and/or the IG-DMR show close to 100%
methylation, indicating that passive loss of methylation or TET2 and TET3 activity are
unlikely and/or unable to compensate in the window between gametogenesis and E10.5
at these loci. One mCON animal also exhibited hypermethylation at the IG-DMR and this
may be because the dam was heterozygous for the Tet1 allele.
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In addition to expanding Tet1’s role to regulation of DNA methylation in the
female germline, we report for the first time that loss of TET1 leads to biallelic expression
of paternally expressed genes when the deletion is inherited from the maternal lineage.
At E10.5, we observe completely biallelic expression of Igf2. This level of expression from
the normally silent maternal allele corresponds to the level of dysregulation of ICR
methylation, which is close to 100% methylated in all of the affected offspring. Biallelic
expression of Igf2 is also observed at the newborn P0 stage and is consistent across
tissues from different germ layers. The proportion of animals with biallelic expression is
consistent between the embryonic stage and the newborn stage. These results suggest
that alterations at the H19/Igf2 locus are compatible with late gestation development
and live birth, consistent with the fact that biallelic Igf2 is detected in a subset of
Beckwith-Wiedemann patients (Kalish et al., 2014). It will be interesting to determine if
animals with biallelic Igf2 expression develop human imprinting disorder-like
phenotypes postnatally. Such a result would indicate that misregulation of Tet1 may be a
cause of idiopathic cases of human imprinting disorders.
To date, previous studies regarding Tet1 and genomic imprinting have relied on
measuring total expression of imprinted genes. Our data demonstrate that
hypermethylation of the H19/Igf2 ICR and the IG-DMR is associated with silencing of
the maternally-expressed genes, H19 and Meg3, respectively. However, total levels of
expression of the corresponding paternally expressed genes, Igf2 and Dlk1, do not
perfectly predict biallelic expression. This is consistent with other reports in the
literature describing inconsistencies between total and allele-specific expression
(Eckersley-Maslin and Spector, 2014). Moreover, our results contrast with Yamaguchi et
al., 2013, where decreases in total expression of both maternally and paternally
expressed genes at the IG-DMR were observed in E19.5 placentas of resorbed embryos.
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These discrepancies could potentially be due to differences in the quality of the input
material from resorption sites.
In this study, we demonstrate that despite equal sex ratios of Tet1 mKO offspring
at each developmental stage examined, imprinting phenotypes are biased towards
females at the H19/Igf2 ICR and the IG-DMR. This result is unexpected, as sex-biased
imprinting phenotypes have yet to be described by other groups working with mouse
models of Tet1 (Dawlaty et al., 2013; Yamaguchi et al., 2013; Zhang et al., 2016b).
However, the nature of this sex-biased effect is unclear. While there have been previous
reports of sex-specific differences in total expression of certain imprinted genes such as
H19 and Igf2 in the E14.5 brain, these changes were not observed before sexdetermination at E10.5 (Faisal et al., 2014). As our bias is observed before sex
differentiation, it is likely that differences in sex steroids are not playing a major role in
our animals. One possibility is that both male and female mKO offspring have
hypermethylation at the H19/Igf2 ICR and the IG-DMR, but this abnormal methylation
is not maintained in males. It is also possible that imprinting abnormalities at the
H19/Igf2 ICR and the IG-DMR as well as defects at another locus (or multiple loci) are
both embryonic lethal but affect each sex independently. In this circumstance, we
envision that dysregulated imprinting at the IG-DMR and the H19/Igf2 ICR is more
detrimental in males, but methylation or expression defects elsewhere caused by loss of
Tet1 may be more detrimental in females. This scenario is compatible with the early
lethality we observed at E10.5 and is also consistent with the equal sex ratios we
observed at this developmental stage. Further studies are warranted to understand this
mechanism.
In addition to our female germline and offspring analysis, we also investigated
the function of TET1 in the male germline. We demonstrate that lack of TET1 leads to
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hypermethylation of the maternally methylated ICRs, KvDMR, Peg1, and Peg3. The
hypermethylation of KvDMR is consistent with reduced-representation bisulfite
sequencing data from Yamaguchi et al., 2013. Additionally, Dawlaty et al., 2013 reported
hypermethylation of Peg1, Peg3, and the KvDMR by methylated DNA
immunoprecipitation and sequencing analysis. We additionally detected no significant
difference in hypermethylation between Tet1 KO and combined Tet1/Tet2 double
knockout sperm (Table S2.5) providing support to the role of TET1 as the primary
isoform responsible for imprint erasure.
While three of the ICRs investigated in our study demonstrated dependency of
TET1 for DNA methylation erasure in sperm, Snrpn was unique in that it was
demethylated regardless of presence of TET1. Both our study and that of Dawlaty et al.,
2013 find that the Snrpn ICR is not hypermethylated in the absence of TET1 or with the
combined deletion of Tet1 and Tet2. This finding is also consistent with experiments
using an aorta-gonad-mesonephros organ culture that recapitulates endogenous PGC
ICR demethylation in vitro. Using this system, the investigators inhibited PGC
proliferation through the use of a PI3-kinase inhibitor and found that Snrpn was unable
to demethylate, while the H19/Igf2 ICR did lose DNA methylation (Calvopina et al.,
2015). Together, these results indicate that the Snrpn ICR relies on passive
demethylation via replication. While the mechanism underlying TET1-independent
demethylation is unknown, the high density of Alu elements belonging to the SINE
family of retroelements surrounding the Snrpn ICR may be relevant (Huq et al., 1997).
SINEs, unlike other repetitive elements, are not resistant to DNA demethylation in the
germline (Seisenberger et al., 2012b) and thus, may influence how Snrpn is
demethylated. Overall, these results show that DNA demethylation of some maternally
methylated ICRs requires TET while others do not.
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Consistent with DNA methylation results from Tet1 KO sperm, Tet1 pKO
offspring also showed hypermethylation of the Peg3 ICR and KvDMR, whereas no
changes in DNA methylation were observed at the Snrpn ICR at both E12.5 and at P0.
Hypermethylation at the KvDMR was coincident with biallelic expression of Cdkn1c.
Unlike the consistent levels of biallelic Igf2 expression observed in offspring of mKO
animals, the amount of abnormal maternal expression of Cdkn1c in pKO offspring was
variable among affected individuals at both time points investigated. For all
developmental stages tested, the variable level of biallelic expression closely mimicked
the levels of DNA hypermethylation and both loss of imprinting and DNA
hypermethylation were consistent across tissues. Given these findings, the variability in
loss of imprinted expression suggests that at the KvDMR locus, activity of the other TET
family members and/or passive dilution may be able to partially compensate between
fertilization and the blastocyst stage when the extraembryonic tissues are specified
Moreover, this biallelic expression was more prevalent in the embryonic stages
compared to the newborn stage. Given the smaller litter size of Tet1 pKO offspring
compared to pCON offspring at E12.5 and at birth, it is possible that embryonic loss
could reduce the number of affected offspring at the later developmental stage.
Similar to our maternal TET1 KO data, the molecular phenotype of pKO offspring was
highly variable. In both male and female offspring, variability in the levels of imprinted
genes at the embryonic stages examined could not be explained by changes in mRNA
levels of Dnmt1, Dnmt3a, Dnmt3b, Dnmt3l, Uhrf1, Tet2, or Tet3 (data not shown). One
potential source of stochasticity could be due to the unique properties of individual
imprinted loci. ICRs can differ in size, genomic and chromatin contexts, sequence,
number and identity of trans-factor binding sites, as well as differences in mechanisms
of genomic imprinting. For example, the KvDMR is large, highly enriched in LINE
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elements, and very CpG rich (Engemann et al., 2000). These inherent differences may
underlie some of the stochastic phenotypes observed in our study. Additionally,
stochasticity of the imprinting phenotypes may be due to meiotic recombination. Even
though some ICRs are on the same parental chromosome, hypermethylation of both loci
is not correlated in a given pup (Fig S2.4). This observation is incompatible with a model
of random segregation of parental alleles. For example, we observe either normal
methylation at the KvDMR and the Peg3 ICR, or hypermethylation of one locus but not
the other, but never hypermethylation at both loci in the same animal. These phenotypes
represent three of the four possible recombination states of meiosis on chromosome 7, as
mice tend to have one or two recombination events per chromosome (Koehler et al.,
2002). Given the proportions of animals we observe with hypermethylation of one of the
two loci, the probability of seeing both hypermethylated loci in one animal is very low.
However, we cannot exclude the possibility that hypermethylation of the KvDMR and
the Peg3 ICR produces a synthetically lethal effect. Lastly, TET1 is a large protein that is
known to interact with epigenetic regulators such as SIN3A, HDAC1, HDAC2, OGT
(Vella et al., 2013; Williams et al., 2011), pluripotency factors like NANOG (Costa et al.,
2013), and has been suggested to play roles in recruiting the EZH2 subunit of the
Polycomb Repressive Complex 2 to distinct sites in the genome (Wu et al., 2011a). Loss
of these interactions may lead to inadequate or inappropriate targeting of these
complexes, contributing to further dysregulation of the epigenome in Tet1 KO animals.
In sum, we present a detailed analysis of the previously unexplored maternal
germline and describe for the first time, allele-specific expression abnormalities in Tet1
KO offspring. Together with sperm and paternal KO studies, we determine that Tet1 is an
important regulator of genomic imprinting in both the maternal and paternal lineages
and ICRs.
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Figure 2.1. Hypermethylation occurs stochastically in Tet1-/- oocytes at the
H19/Igf2 ICR and the IG-DMR.
(A) Schematic depicting the breeding scheme used to collect oocytes from 3.5-week-old
mice. (B) Average DNA methylation at various ICRs. Individual dots represent the
percent DNA methylation from one pool of oocytes collected from one mouse. ICR labels
are color coded according to which parental allele is normally methylated: blue = the
paternal allele; pink = the maternal allele. Line = median, bars = 95% confidence
interval. WT = wild-type (blue); Het = heterozygous (green); KO = Tet1-/- (yellow).
H19/Igf2 & IG-DMR: (n) WT = 5, Het = 5, KO = 8; Peg3 (n) WT = 6, Het = 5, KO = 9.
(C) Calculated variance for each ICR per genotype is graphed. * p < 0.05, ** p < 0.01
(Fligner-Killeen Test).
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Figure 2.2. Abnormal allele-specific expression and methylation of Igf2 in
E10.5 mKO offspring.
(A) The number of live embryos per litter at E10.5. ** p < 0.01, unpaired 2-tailed t-test
(unequal variance). Litters (n) mCON = 5; mKO = 8. (B) The number of resorbed
embryos per litter at E10.5. * p < 0.05, unpaired 2-tailed t-test (unequal variance). (n)
mCON = 5 litters; mKO = 8 litters. (A&B) Line = mean, bars = 95% confidence interval.
(C) Schematic of the H19/Igf2 locus. The maternal allele with maternal-specific H19
expression is represented on the top (pink) and the paternal allele with paternal-specific
Igf2 expression is represented on the bottom (blue). Genes = black boxes. Black
lollipops= methylated DNA at the ICR, white lollipops = unmethylated DNA at the ICR.
(D) Allele-specific expression of Igf2. Abnormal mKO embryos are denoted with red
letters which are consistent between Figures 2.2 and 2.3. All embryos are in the same
order from left to right in Figures 2.2D, 2.2E, and 3.2B. Igf2 (n) mCON = 32 embryos
from 4 litters. mKO = 36 embryos from 7 litters. (E) Average percent DNA methylation
at the H19/Igf2 ICR, (n) mCON = 32 embryos from 4 litters; mKO = 36 embryos from 7
litters. (F) Total expression from qPCR analysis of Igf2 and H19. White columns indicate
the average of one of each of the five mCON litters (n = 8, 8, 8, 9, 9 respectively from left
to right), which were normalized to the expression of Rplp0, Nono, and Rpl13a and set
to 1. Bars represent ± biological S.E.M. The gray columns represent individual mKO
embryos that were run on the same plate as the adjacent mCON column. All mCON
litters and embryos are in the same order in F as in Figure 2.3C. In the H19 plot, H19
expression in embryos A and B is undetectable.
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Figure 2.3. Abnormal methylation and total expression at the IG-DMR in
E10.5 mKO offspring.
(A) Schematic of the IG-DMR locus. The maternal allele and maternal-specific Meg3
expression is represented on the top (pink) and the paternal allele and paternal-specific
Dlk1 expression is represented on the bottom (blue). See Figure 2.2 legend for details.
(B) Percent DNA methylation at the IG-DMR. All embryos are in the same order from
left to right in both Figures 2.3B, 2.2D, and 2.2E. (n) mCON = 32 embryos from 4 litters;
mKO = 36 embryos from 7 litters. ** p < 0.01, Fisher’s Exact Test. (C) Total expression
from qPCR analysis of Dlk1 and Meg3. All mCON litters and embryos are in the same
order between Figures 2.2F and 2.3C. See Figure 2.2 legend for details. In the Meg3 plot,
Meg3 expression in embryos A, D, E, F, G, H, I, J, K, and L is undetectable.
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FIGURE 4
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Figure 2.4. Allelic expression of Igf2 and methylation at the H19/Igf2 ICR is
consistent across different tissues in P0 newborn mKO offspring.
(A) The number of live pups per litter at P0. (n) mCON = 6 litters; mKO = 10 litters. Line
= mean, bars = 95% confidence interval. (B) Biallelic expression of Igf2
in two mKO pups is consistent between tongue and liver. (n) mCON = 16 pups from 3
litters; mKO = 31 pups from 7 litters. Abnormal pups are denoted with red letters and
indicate the same pups between graphs. All pups are in the same order from left to right
in both the liver and tongue graphs.
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Figure 2.5. Hypermethylation occurs at a subset of ICRs in Tet1-/- sperm.
(A) Schematic depicting the breeding scheme used to collect mature sperm. (B)
Individual dots represent the percent DNA methylation for sperm collected from one
adult mouse. ICR labels are color coded according to which parental allele is normally
methylated: blue= the paternal allele; pink = the maternal allele. Line = median, bars =
95% confidence interval. ** = p < 0.01, **** = p < 0.0001, WT vs KO, Two-tailed MannWhitney Rank-Sum Test. H19/Igf2 (n) WT = 5, Het = 9, KO = 14; IG-DMR & Peg1 (n)
WT = 4, Het = 8, KO = 11; KvDMR & Snrpn (n) WT = 6, Het = 10, KO = 15; Peg3 (n) WT
= 6, Het = 10, KO = 14.
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FIGURE 6
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Figure 2.6. Biallelic expression of Cdkn1c is prevalent in E12.5 pKO
offspring.
(A) The number of live embryos per litter at E12.5. (B) The number of resorbed embryos
per litter at E12.5. (A&B) (n) pCON = 4 litters; pKO = 5 litters. Line = mean, bars = 95%
confidence interval. * p < 0.05, unpaired two-tailed t-test. (C) Schematic of the KvDMR
locus. The maternal allele and maternal-specific Cdkn1c and Kcnq1 expression is
represented on the top (pink) and the paternal allele and paternal-specific Kcnq1ot1
expression is represented on the bottom (blue). Genes = black boxes with the exception
of Kcnq1ot1, which is represented as white box within the gene body of Kcnq1. Black
lollipops= methylated DNA at the ICR, white lollipops = unmethylated DNA at the ICR.
(D) Allele-specific expression of Cdkn1c. (n) pCON = 23 embryos from 3 litters; pKO =
25 embryos from 7 litters. Abnormal embryos are indicated with red letters, which is
consistent in graphs D and E. All embryos are in the same order from left to right in D
and E. (E) Percent DNA methylation at the KvDMR. (n) pCON = 19 embryos from 3
litters; pKO = 29 embryos from 7 litters.
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FIGURE 7
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Figure 2.7. P0 pKO pups show biallelic Cdkn1c expression and methylation
defects across tissues.
(A) Allele-specific expression of Cdkn1c in P0 brain, tongue, and liver. (n) pCON = 23
pups from 4 litters; pKO = 29 pups from 5 litters. Abnormal pups are denoted with
unique red letters, which are consistent in parts A and B. All pups are in the same order
from left to right in all graphs in both parts A and B. (B) Percent DNA methylation at the
KvDMR. (n) pCON = 19 pups from 4 litters; pKO = 29 pups from 5 litters. (C) The
number of live pups per litter at P0, **** p < 0.0001, unpaired two-tailed t-test. (n)
pCON = 5 litters; pKO = 13 litters. Line = mean, bars = 95% confidence interval.
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Supplemental Figure 2.1. Further characterization of oocyte DNA
methylation. The DNA methylation data from Figure 2.1 (A) KO oocytes at the
H19/Igf2 ICR and (B) KO oocytes at the IG-DMR are plotted as histograms. (C)
Correlation plot between KO oocyte pools at the H19/Igf2 ICR versus the IG-DMR. r =
Spearman correlation coefficient. Dashed line represents a hypothetical perfect
correlation.
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Supplemental Figure 2. F1 hybrid breeding schemes for analyzing allele-specific expression. (A)

Supplemental
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2.2.
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on the B6
background
were mated
to Tet1+/+schemes
mice on the for
C7 background
to generate
+/- female mice on
-/- the B6 background were mated to
specific
expression.
(A)
Tet1
maternal control offspring (mCON) for analysis. (B) Tet1 female mice on the B6 background were
mated
to Tet1
mice
the C7 background
to generatematernal
maternal KO
offspringoffspring
(mKO) for analysis.
(C)for
Tet1+/+
mice
on+/+the
C7onbackground
to generate
control
(mCON)
+/+
+/Tet1
females
on
the
C7
background
were
crossed
to
Tet
males
on
the
B6
background
to
generate
-/+/+
analysis. (B) Tet1 female mice on the B6 background
were mated to Tet1 mice on the
paternal control offspring (pCON) for analysis. (D) Tet1+/+ females on the C7 background were crossed
C7 background
to
generate
maternal
KO
offspring
(mKO)
for analysis. (C) Tet1+/+
-/to Tet1 males on the B6 background to generate paternal KO offspring (pKO) for analysis.
+/females on the C7 background were crossed to Tet males on the B6 background to
generate paternal control offspring (pCON) for analysis. (D) Tet1+/+ females on the C7
background were crossed to Tet1-/- males on the B6 background to generate paternal KO
offspring (pKO) for analysis.
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Supplemental Figure 2.5. Abnormal biallelic expression and DNA
hypermethylation are consistent in the E12.5 placental tissues. (A) Allelespecific expression of Cdkn1c in the E12.5 placenta (corresponding to the embryos from
Figure 6 in the main text). Cdkn1c (n) pCON = 24 placentas from 3 litters; pKO = 29
placentas from 7 litters. (B) Percent DNA methylation at the KvDMR. (n) pCON = 16
placentas from 2 litters; pKO = 29 placentas from 7 litters. Abnormal placentas are
indicated with red letters and this lettering is consistent between all graphs in Figures
2.6B and 2.6C and Supplemental Figures 2.5A and 2.5B. All placentas are in the same
order from left to right in A and B.
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Table S2.3: Sex ratio information for both maternal and paternal Tet1 offspring.
Maternal E10.5

mCON
Observed
Expected
Male
21
17
Female
13
17
TOTAL
34
34
Two-tailed Chi-Square: p = 0.170
Sex ratio is not significantly different

Maternal E10.5

TOTAL
38
30
68

mKO
Observed
Male
18
Female
18
TOTAL
36
Two-tailed Chi-Square: 1.000
Sex ratio is not significantly different
Maternal E10.5
Male
Female

mKO
Affected
3
9

Expected
18
18
36

TOTAL
36
36
72

Unaffected
16
8

The two-tailed P value = 0.033
The association between rows and columns is significant.
Maternal P0

mCON
Observed
Expected
Male
8
8
Female
8
8
TOTAL
16
16
Two-tailed Chi-Square: p = 1.000
Sex ratio is not significantly different

Maternal P0

TOTAL
16
16
32

mKO
Observed
Male
14
Female
16
TOTAL
30
Two-tailed Chi-Square: p = 0.715
Sex ratio is not significantly different

Expected
15
15
30

TOTAL
29
31
60

Maternal P0

mKO
Affected
Unaffected
Male
0
16
Female
3
13
Affected = J, K, and # (see Table S2.6)
Two-tailed Fisher's Exact Test: p = 0.226
The association between rows and columns is not significant.
Paternal E12.5

pCON
Observed
Expected
Male
11
11.5
Female
12
11.5
TOTAL
23
23
Two-tailed Chi-Square: p = 0.835
Sex ratio is not significantly different

Paternal E12.5

TOTAL
22.5
23.5
46

pKO
Observed
Male
10
Female
19
TOTAL
29
Two-tailed Chi-Square: p = 0.095
Sex ratio is not significantly different

Expected
14.5
14.5
29

TOTAL
24.5
33.5
58

Paternal E12.5

pKO
Affected
Unaffected
Male
3
7
Female
4
15
Two-tailed Fisher's Exact Test: p = 0.665
The association between rows and columns is not significant.
Paternal P0

pCON
Observed
Expected
Male
13
11.5
Female
10
11.5
TOTAL
23
23
Two-tailed Chi-Square: p = 0.532
Sex ratio is not significantly different

Paternal P0

TOTAL
24.5
21.5
46

pKO
Observed
Male
17
Female
11
TOTAL
28
Two-tailed Chi-Square: p = 0.257
Sex ratio is not significantly different
Paternal P0

Expected
14
14
28

pKO
Affected
Unaffected
Male
0
17
Female
3
8
Two-tailed Fisher's Exact Test: p = 0.050
The association between rows and columns is not significant.
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TOTAL
31
25
56

Table S2.4: Litter (denoted with unique letters), sex (M= male, F = female), allele-specific expression, and DNA methylation data for all P0 mCON and mKO brain, liver, and tongue.
Allele-Specific Expression- %
Expression from normally repressed
allele

ICR DNA Methylation- (% Average)

H19
Igf2
H19/Igf2
IG-DMR
Peg3
KvDMR
Cross Original ID
Paper ID
Sex Litter Brain Liver Tongue Brain Liver Tongue Brain Liver Tongue Brain Liver Tongue Brain Liver Tongue Brain Liver Tongue
mCON
5313-1
F
A
0.0
0.0
0.0
0.0
63.3
51.9
53.1
57.1
mCON
5313-2
M
A
0.0
0.0
0.0
0.0
57.1
49.9
50.8
51.8
mCON
5313-3
M
A
0.0
0.0
0.0
0.0
58.9
48.3
52.8
52.2
mCON
5313-4
F
A
0.0
0.0
0.0
0.0
57.5
45.8
51.2
52.1
mCON
5313-5
M
A
0.0
0.0
0.0
0.0
57.7
45.6
51.5
51.1
mCON
5313-6
F
A
0.0
0.0
0.0
0.0
55.4
48.4
51.5
51.8
mCON
5314-1
F
B
0.0
0.0
0.0
0.0
57.6
49.5
51.5
51.4
mCON
5314-2
M
B
0.0
0.0
0.0
0.0
58.4
49.8
53.0
52.0
mCON
5314-3
M
B
0.0
0.0
0.0
0.0
61.6
48.6
52.4
52.7
mCON
1330-1
F
C
0.0
0.0
0.0
0.0
59.8
48.1
51.6
54.6
mCON
1330-2
F
C
0.0
0.0
0.0
0.0
57.0
46.6
55.1
mCON
1330-3
F
C
0.0
0.0
0.0
0.0
55.9
44.2
54.0
49.7
mCON
1330-4
M
C
0.0
0.0
0.0
0.0
59.4
46.2
51.9
50.7
mCON
1330-5
M
C
0.0
0.0
0.0
0.0
55.6
48.1
52.6
51.0
mCON
1330-6
F
C
0.0
0.0
0.0
0.0
55.6
47.4
51.0
53.3
mCON
1330-7
M
C
0.0
0.0
0.0
0.0
57.7
45.9
52.7
53.0
mKO
5106-1
M
D
0.0
0.0
0.0
0.0
58.3
48.9
53.2
52.7
mKO
5106-2
F
D
0.0
0.0
0.0
0.0
57.5
52.6
53.4
52.6
mKO
5106-3
M
D
0.0
0.0
0.0
0.0
58.6
48.3
50.7
52.7
mKO
5106-4
F
D
0.0
0.0
0.0
0.0
58.4
46.8
50.3
51.3
mKO
5106-5
M
D
0.0
0.0
0.0
0.0
50.6
49.3
50.0
53.4
mKO
5106-6
F
D
0.0
0.0
0.0
0.0
60.0
51.9
52.6
51.6
mKO
5108-1
F
E
0.0
0.0
0.0
0.0
55.1
46.4
51.5
51.2
mKO
5108-2
M
E
0.0
0.0
0.0
0.0
55.7
45.1
51.1
50.6
mKO
5108-3
M
E
0.0
0.0
0.0
0.0
58.4
46.1
53.2
49.8
mKO
5108-4
F
E
0.0
0.0
0.0
0.0
58.7
45.4
52.9
53.7
mKO
5108-5
J
F
E
0.0
0.0
39.4 52.1
86.0
43.5
52.1
48.7
mKO
5108-6
F
E
0.0
0.0
0.0
0.0
55.7
47.2
52.9
52.3
mKO
5106-7
F
F
0.0
0.0
0.0
0.0
62.6
48.0
43.8
52.4
mKO
5106-8
M
F
0.0
0.0
0.0
0.0
53.5
44.0
53.2
51.3
mKO
5106-9
M
F
0.0
0.0
0.0
0.0
58.8
45.3
56.1
53.2
mKO
5106-10
F
0.0
0.0
0.0
0.0
49.1
42.0
40.6
64.6
mKO
5106-11
M
F
0.0
0.0
0.0
0.0
57.5
41.6
51.0
52.1
mKO
5106-12
F
F
0.0
0.0
0.0
0.0
56.4
47.3
52.5
51.5
mKO
5106-13
M
F
0.0
0.0
0.0
0.0
62.7
47.1
53.3
47.6
mKO
mKO-8
F
G
0.0
0.0
0.0
0.0
60.4
46.6
51.9
51.2
mKO
mKO-9
F
G
0.0
0.0
0.0
0.0
57.0
51.1
51.8
51.3
mKO
mKO-10
F
G
0.0
0.0
0.0
0.0
57.1
49.4
52.4
54.6
mKO
912-1
# (See IG-DMR & Table S2.5) F
H
0.0
0.0
57.6
94.2
52.6
54.1
mKO
912-2
F
H
0.0
0.0
0.0
0.0
57.2
50.4
52.0
52.8
mKO
912-3
M
H
0.0
0.0
0.0
0.0
58.9
50.4
50.8
55.3
mKO
912-4
M
H
0.0
0.0
0.0
0.0
59.1
53.2
51.7
56.1
mKO
912-5
F
H
0.0
0.0
0.0
0.0
59.1
49.4
51.7
52.3
mKO
912-6
M
I
0.0
0.0
0.0
0.0
57.8
49.0
50.5
52.1
mKO
912-7
M
I
0.0
0.0
0.0
0.0
57.2
48.8
51.5
51.8
mKO
976-2
K
F
J
0.0
0.0
6.7
11.7
60.2
50.2
50.8
52.5
mKO
976-3
M
J
0.0
0.0
0.0
0.0
58.9
52.4
51.7
53.7
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Table S2.5: % DNA methylation at ICRs in Tet1 Sperm
ICR DNA Methylation (% Average)
Paternally Methylated
Sample ID Genotype

H19/Igf2

KvDMR

Peg3

8.5
2.5
11.0
12.0
7.0
3.8
4.0
4.4
9.6
4.5
4.8
3.8
4.4
6.7
5.3
4.4

7.3
1.6
8.0
4.0
5.0
3.3
3.4
2.9
5.3
3.6
6.0
3.3
6.0
5.0
5.3
3.4
3.0

96.1
96.4
95.6
88.4
96.2
89.4
95.5
95.1
97.2

29.8
33.6
30.9
33.9
32.7
39.0
33.8
34.3
31.3
36.5
34.4
37.9
34.2
35.8
35.5

4.6
10.6
10.3
9.8
10.8
11.6
10.7
19.9
11.7
11.9
10.4
11.2
9.8

94.0
96.0
96.0

93.0
96.0
93.0

23.0
30.0
37.0

H19/Igf2

IG-DMR

0.985

0.440

W5062
W5068
WT1
WT2
WT3
WT5183
H4852
H5059
H5069
H5103
H5104
H5105
H5184
Hep3
Het5787
Het5791

WT
WT
WT
WT
WT
WT
Het
Het
Het
Het
Het
Het
Het
Het
Het
Het

94.6
95.7
96.0
96.0
94.0
97.6
95.4
93.7
97.7
95.9
94.0
95.0
94.1
93.9
97.4
97.1

M4848
M4851
M4859
M5060
M5064
M5109
M5311
Mutep3
Mutep4
Mut5339
Mut5781
Mut5318
Mut5333
Mut5058
Mut5728

KO
KO
KO
KO
KO
KO
KO
KO
KO
KO
KO
KO
KO
KO
KO

95.2
93.7
95.0
94.8
96.8
91.6
92.6
93.0
96.9
91.7
96.8
95.2
96.2
96.5
96.8

DKO 1
DKO 2
DKO 3

DKO
DKO
DKO

KO vs DKO, MannWhitney (p-value)

IG-DMR

Maternally Methylated

95.0
95.0
92.0
97.6
96.9
97.4
95.4
97.3
96.3
97.0
96.9
97.2

Peg1

5.0
5.0
8.0
4.8
5.8
5.4
6.4
6.9
5.5
6.1
8.2
6.6

Snrpn
5.1
2.3
7.0
3.0
6.0
3.2
4.2
4.5
13.8
6.8
4.6
5.9
2.3
5.3
5.0
3.9

18.9
23.5
21.2
26.0
19.8
21.4
18.4
21.4
17.3

5.6
18.5
14.2
5.1
5.9
28.8
6.1
7.0
3.1
10.1
5.4
5.5
5.2
5.2
3.1

6.0
5.0
9.0

10.0
20.0
22.0

7.0
8.0
11.0

KvDMR

Peg3

Peg1

Snrpn

0.360

0.065

0.660

0.203

95.1
95.9

68

20.4
21.5
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CHAPTER 3: FUTURE DIRECTIONS
Our lab’s experiments and other recent studies employing knockdown and
knockout models have explored whether the TET enzymes may play a role in the two
waves of DNA methylation that occur during development. These studies demonstrated
that lack of TET1 led to aberrant levels of DNA methylation at ICRs, abnormal total
expression of imprinted genes, and loss of imprinting (Dawlaty et al., 2013; SanMiguel et
al., 2018; Yamaguchi et al., 2013). However, Tet1 and Tet2 are both expressed in PGCs.
While evidence from our sperm DNA methylation studies (see Chapter 2) indicates TET2
is not contributing to the normal DNA demethylation in PGCs, without dissecting 5hmC
from 5mC profiles, we cannot definitively rule out contributions from TET2 during PGC
reprogramming. Additionally, it remains unclear how TET1 is recruited to chromatin
during PGC demethylation. Given the importance on monoallelic imprinted gene
expression to healthy mammalian development, it is critical to understand what factors
regulate TET1 binding and thus affect ICR demethylation. Moreover, understanding the
role of TET1 in this important developmental process may lead to further insight into
human imprinting disease etiologies.

3.1 Parse the requirements of individual TET proteins for ICR
demethylation during PGC reprogramming in mice.
Tet1 homozygous null sperm and oocytes show defects in erasing DNA
methylation at ICRs. This hypermethylation phenotype was not significantly worse in
Tet1; Tet2 double knockout sperm. However, this methylation was assayed by bisulfite
treatment followed by pyrosequencing, and this method cannot distinguish 5mC from
5hmC. Thus, the possibility still remains that despite similar total levels of modified
5mC/5hmC, the ratios may actually be different between the groups. If this were true,
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this would point to a role for Tet2 in this demethylation of ICRs as well. While seemingly
not a player in PGCs due to its low to undetectable expression in PGCs, if any amount of
TET3 were present, this could also potentially lead to low levels of compensation and
may partially explain the variability in phenotype in some of our offspring. Indeed,
despite undetectable levels of TET3 in ESCs, another cell type with TET expression
similar to PGCs, in Tet1; Tet2 DKOs, 2% of 5hmC remained as assayed by mass spec.
Only when all three family members were deleted did the 5hmC levels drop to 0% (Lu et
al., 2014). Therefore, deleting Tet3 after its described role in the early embryo may also
be worth examining.
Previously, levels of 5hmC in WT PGCs were measured using Glu-qPCR and
showed 5hmC accumulation at four ICRs during demethylation. However, this technique
relies on a single CCGG site within a locus and these experiments did not address how
5hmC accumulation changes in the in vivo context of Tet deletions in mice (Hajkova et
al., 2010). Additionally, 5mC was analyzed in Tet3; TNAP-cre sperm and oocytes using
TaqI or BstUI digestion and showed normal WT levels of 5mC. However, these analyses
again depend on only one TCGA site, and the number of biological replicates appears to
be n=1 (Gu et al., 2011). Therefore, to determine the precise roles of each TET family
member, it will be crucial to examine 5hmC and 5mC levels in the context of different Tet
deletions. Additionally, profiling 5hmC during different time points in PGCs as they
demethylate will address whether hypermethylation at ICRs is a direct effect of losing of
TET1. Given the low numbers of PGCs, this analysis has until now been difficult.
However, the development of a new, bisulfite-free method of marking 5hmC in genomic
DNA, called Apobec-coupled epigenetic sequencing (ACE-seq), is highly amenable to low
input, long reads, and can be analyzed by any sequencing method, including whole
genome sequencing or pyrosequencing (Schutsky et al., under review and personal
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communication). To address these questions, we would profile 5hmC using ACE-seq in
both WT and TET1 KO PGCs from E10.5- E13.5. To accomplish this goal, the Tet1 allele
has been crossed into a Oct4-eGFP reporter line that drives GFP expression specifically
in germ cells starting at E9.5 (Fig 3.1) (Hargan-Calvopina et al., 2016; Lengner et al.,
2007). My current efforts have involved collecting gonads at E13.5 and E12. 5. We have
successfully dissociated the gonads and used flow cytometry to measure EGFP. The next
steps will be to use fluorescence-activated cell sorting (FACS) to collect these cells for
analysis (Fig 3.1). In addition to our Tet1 KO mouse model, floxed alleles of both Tet2
and Tet3 exist. Thus, it would also be useful to address their contribution by using the
TNAP-Cre line which expressed Cre recombinase as early as E9.5 in PGCs. This
conditional approach would bypass the early embryo requirement for Tet3 and would
eliminate or reduce any confounding effects from reducing Tet expression in other cell
types. Both male and female PGCs should be profiled in order to determine the effects of
Tet1 deletion on maternally methylated, and paternally methylated ICRs, respectively.
Given that no imprinting defects have been reported for Tet2 KO mice, and our
data in sperm thus far, I do not expect to see a difference in levels of 5hmC at the ICRs
between the WT mouse and the Tet1 KO mouse germ cells. However, measuring 5hmC
levels in PGCs in the context of different TET deletions would conclusively determine the
precise contributions of each TET protein to this process. A potential drawback with this
approach would be if Cre recombination is variable between mice, particularly at the
early E10.5 time point, which could potentially confound our results. An alternative
would be to use a ubiquitous Cre driver to delete Tet2 early in development, but this
would preclude analysis of Tet3 KO PGCs. Another drawback may be profiling in bulk
PGCs. As the technology develops, applying single-cell ACE-seq to PGCs may help
elucidate the underlying causes of stochasticity and variability in our mice.
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3.2 Determine if epigenetic factors control TET1 binding at specific
ICRs during demethylation.
TET1 binding sites have been defined in embryonic stem cells (ESCs), a proxy for
the inner cell mass of the early embryo. However, in ESCs, TET1 is not present at ICRs as
determined by ChIP-seq (Fig 3.3) (Williams et al., 2011). Despite evidence that 5hmC can
accumulate at a subset of ICRs in PGCs during DNA demethylation (Hackett et al.,
2013), how and when TET1 is recruited to ICRs in PGCs remains unknown.
Multiple lines of evidence suggest that histone modifications play a role in ICR
methylation dynamics. For example, H3K4me3 has been shown to prevent binding of
DNMT3A and its cofactor DNMT3L during DNA methylation reestablishment in germ
cells, but when H3K4 is unmethylated, DNMTs can bind and reestablish DNA
methylation patterns (Fournier et al., 2002). Additionally, a progressive loss of
H3K9me2/3 occurs concurrently with the DNA demethylation wave in PGCs, while
concomitant accumulation of H3K27me3 also occurs (Hajkova et al., 2008; Seki et al.,
2005). Strong evidence suggests that H3K9me2/3 may play a potential role in TET1
demethylation at ICRs; firstly, both of these marks are enriched on the methylated ICR
and are associated with heterochromatin (Bannister et al., 2001; Delaval et al., 2007;
Fournier et al., 2002; Henckel et al., 2009; Lachner et al., 2001). In addition, deletion of
the enzymes responsible for establishing these marks resulted in altered DNA
methylation at imprinted genes (Dong et al., 2008; Leung et al., 2014; Tachibana et al.,
2008; Xin et al., 2003). DPPA3 binds to H3K9me2 in zygotes and this binding helps
protect ICRs from erasure during the first wave of demethylation. Lastly, in ESCs, the
histone methyltransferases G9a and GLP are required for recruitment of DNMTs to
imprinted loci, and this recruitment antagonizes TET activity at these loci (Zhang et al.,
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2016a). Taken together, I hypothesize that particular chromatin environments are
permissive or repressive to TET1 interactions and this is what controls the timing of
TET1 binding and demethylation of ICRs in PGCs.
Our Tet1 KO sperm data demonstrates that TET1 is required at both an early- and
a late-DNA demethylating ICR (KvDMR and Peg3 ICR, respectively (Hackett et al.,
2013))(SanMiguel et al., 2018). Because both of these loci depend on TET1 for
demethylation, but are demethylated asynchronously, these ICRs are likely to have
differences in chromatin states during DNA demethylation in PGCs. As such, these ICRs
can be used as model loci to determine how histone modification enrichment,
specifically, H3K9me2/3 marks, correlate with TET1 occupancy given the relationship of
these PTMs to DNA methylation at ICRs. To specifically test a causal role for changes in
these modifications, the CRISPR-Cas9 system can be used. This system allows efficient
targeting of fusions to specific genomic loci using an engineered guide RNA (Dong et al.,
2008; Xin et al., 2003). By targeting writers and erasers of H3K9me2/3 to KvDMR and
Peg3 ICR, respectively, it may be possible to determine if perturbing the chromatin
environment in in vitro primordial germ cell-like cells (PGCLCs) alters TET1 recruitment
using 5hmC as a proxy and DNA demethylation dynamics using bisulfite sequencing.
These experiments will test the hypothesis that TET1 is recruited or blocked from
binding to specific sites in PGCs depending on H3K9me2/3 presence or absence and will
be an important step in understanding how demethylation is regulated.
To isolate PGCs for this analysis, the Pou5f1-EGFP reporter mouse will be used as
described in section 3.1. First, PGCs will be isolated by microdissecting gonadal regions
of embryos at time points corresponding to early, middle, and late DNA demethylation:
E10.5 (early), E11.5 (late), and E12.5 (demethylated). FACS sorting will be used to
separate the EGFP+ PGCs from the EGFP- somatic cells. The somatic cells do not express
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Tet1 highly at this stage nor do they undergo demethylation at these time points
(Hayashi et al., 2011). PGCs and somatic cells will be pooled respectively for downstream
analyses.
In order to perturb histone modifications in a relevant cell type, PGCLCs can be
used (Hayashi and Saitou, 2013; Hayashi et al., 2011). Briefly, these cells are derived
from ESCs and are induced to an epiblast-like state in two days. On the second day, the
cells are subsequently cultured for six days in floating conditions in GMEM with a
defined cocktail of growth factors. At this time, the cells express PGC-specific genes,
exhibit globally decreased H3K9me2 as shown by dot blot analysis, and have decreased
DNA methylation at the early-demethylated imprinted ICR KvDMR (Hayashi et al.,
2011). To verify that the PGCLCs recapitulate many of the epigenetic changes that occur
in vivo and are the most relevant cell type in which to test the fusion proteins, it will be
important to assay H3K9me2/3 by ChIP, and 5mC and 5hmC levels via pyrosequencing
and ACE-seq in PGCs and PGCLCs in our own laboratory. It will be important to use lowcell number ChIP-qPCR (Sachs et al., 2013) for H3K9me2, H3K9me3, and TET1 if
possible (see below), as well as total histone H3 (H3) and IgG control antibodies at the
early-demethylating ICRs, KvDMR and Igf2, and compare them to the latedemethylating ICRs Peg3 and Peg10 in PGCs and somatic cells isolated directly from
mice. We have also designed negative and positive control ChIP-qPCR primers for the
factors of interest. For these protocols as few as 10,000 cells can be used per ChIP
immunoprecipitation (Sachs et al., 2013). As uniform sonication of chromatin will be
essential, up to 50,000 PGCs or somatic cells should be pooled for sonication. These
pools can then be divided into aliquots for the aforementioned ChIP experiments.
Replicates of the ChIP should be performed with an independent cohort of mice.
PGCLCs can generate up to 105 to 106 cells (Hayashi and Saitou, 2013; Hayashi et al.,
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2011), which can also be sonicated and aliquoted for ChIP experiments as described for
the PGCs.
I expect H3K9me2/3 enrichment to inversely correlate with 5hmC accumulation
and thus TET1 binding and demethylation timing. To specifically test whether addition
or removal of these marks from ICRs alters TET1 activity at these sites and thus TET1
dependence for DNA methylation erasure, targeted epigenomic modifiers could be used.
For example, fusion of the catalytic domains of the histone methyltransferases, G9A and
SUV39H1 (both previously used in zinc-finger protein (Couture et al., 2007; Snowden et
al., 2002) as well as the histone demethylase KDM4A (Couture et al., 2007), to the
catalytically-inactive Cas9 protein (dCas9) under the control of an inducible tetracycline
responsive element (TRE) promoter could be generated (Kearns et al., 2013; Ochiai et
al., 2015). Multiple single guide RNAs (sgRNAs) are complementary to KvDMR and
Peg3 ICRs as determined by using the CRISPR design website http://crispr.mit.edu/
which is based on the sequence specificities as determined by Hsu et al. 2013 (Hsu et al.,
2013). These sgRNAs recruit the dCas9 fusion proteins to a specific genomic locus to
alter the chromatin environment. The CRIPSR-Cas9 approach may be the most effective
epigenomic modifying system as it appears to bind DNA irrespective of its DNA
methylation state. Additionally, the use of this platform allows for multiple sgRNAs to be
generated in a short amount of time, as well as the ability to simultaneously co-transfect
multiple guide RNAs to enhance the levels of histone modification changes across a
broader region of the locus. The use of an inducible promoter will allow control of
expression of the fusion proteins only when the PGCLCs have completed their
differentiation so that the addition or removal of the repressive histone modifications
occurs only when DNA demethylation proceeds in these cells (Bisht et al., 2017).
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It will be important to test both transient transfection using Lipofectamine 2000
and lentiviral transduction of plasmids containing the dCas9- fusions, various guide
RNAs and rTTA into ESCs. Pilot ESCs transfections and transductions to select which
sgRNAs afford the best dCas9 recruitment and levels and timing of doxycycline
induction needed. The efficiency of the CRISPR fusions can be assayed by measuring
H3K9me2 and H3K9me3 by ChIP-qPCR, as well as pyrosequencing and ACE-seq. Once
conditions have been optimized, ESCs can be differentiated into PGCLCs and CRISPR
construct expression can be induced with doxycycline. By targeting dCas9-G9A or
dCas9-SUV39H1 to the KvDMR, it will be possible to test if retention of one or both of
these marks can prevent TET1 binding and demethylation of this ICR. Following the
same cloning and cell derivation strategy, it can be determined if targeting the histone
demethylase domain of the KDM4A promotes earlier TET1 binding and earlier erasure of
the TET1-dependent ICR of Peg3. To determine if the effects of the CRISPR fusions are
specific to the catalytic activity and not simply chromatin binding, a dCas9 fused to a
dominant negative version of the G9A catalytic domain (Gyory et al., 2004) as well as
dCas9 fused to a known point mutant which abolishes demethylation activity should be
included as controls (Yamane et al., 2006).
Given the strong evidence linking DNA methylation to the repressive histone
marks H3K9me2 and H3K9me3, I expect to find that these histone marks are present at
ICRs, correlating with DNA methylation and with little to no overlapping enrichment of
TET1 and/or 5hmC. Inversely, I expect that immediately prior to or as demethylation
begins, there will be little H3K9me2/3 correlating with enrichment of TET1. As such, I
would expect that targeting G9A (H3K9me2 writer) or SUV39H1 (H3K9me3 writer) to
early demethylating ICRs in PGCLCs would prevent TET1 binding and thus prevent the
ICR from becoming demethylated. Consistently, I would expect that targeting the eraser
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of H3K9me2/3 to lead to the late-demethylating ICRs will promote earlier TET1 binding
and DNA demethylation (Fig 3.4). These results would support the hypothesis that the
local chromatin environment can prevent or facilitate TET1 binding, thus influencing
DNA demethylation dynamics. These results would be consistent with the roles of
histone modifications affecting other DNA methylation modifiers, such as the protective
state of DPPA3 bound to H3K9me2, which protects ICRs during zygotic reprogramming
following fertilization, as well as H3K4me3 which prevents the de novo DNA
methyltransferase DNMT3A and its cofactor DNMT3L from reestablishing DNA
methylation patterns. I would not expect any phenotypic consequence of changing an
early-demethylated ICR to a late-demethylated ICR, or vice versa, other than the
molecular phenotype in the in vitro system. This is because timing of erasure may be due
to the underlying chromatin environment and/or accessibility of the locus. Therefore, if
erasure is still complete at the proper developmental stage, the ICRs can then be
properly methylated during subsequent germ cell development with appropriate timing.
In vivo, chronic expression of the dCas9-G9A fusion could prevent ICRs from
demethylating in the appropriate developmental window, and this could lead to
abnormal expression of imprinted genes similar to the expected molecular phenotypes of
the Tet1 KO mice.
Reports have demonstrated that TET1 binding does not necessarily correlate with
5hmC enrichment in the genome (Zhang et al., 2016b). Thus, assaying 5hmC serves not
only as a proxy for TET1 binding, but as a direct indicator of TET1 activity. However, it
could also be possible that TET2 is compensating at ICRs. Thus, it may be necessary to
study TET1 activity in the absence of TET2. The most straightforward way to do this
would be to use the mice with a Tet2 floxed allele and/or PGCLCs derived from ESCs null
for Tet2. It is possible that there will not be any correlation with early erasure, TET1
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binding, and lack of H3K9me2/3, or that different histone modifications are
permissive/repressive to TET1 binding. If so, an unbiased approach using mass
spectrometry could be used to determine histone modifications enriched in a TET1 pulldown using chromatin from FACS-sorted PGCs. Using histone modifications present in
PGCs, but depleted from a TET1 pull-down, would generate a list of candidate histone
marks to test. Additionally, recombinant TET1 could be used in conjunction with the
MODified histone peptide array from Active Motif, which could also narrow down the list
of modifications including combinatorial modifications that are permissive to TET1,
leaving the rest as candidates that may repress TET1 binding in vivo. Additionally, TET1
might not bind directly to modifications but to a protective protein that does bind, such
as DPPA3. Thus, assessing DPPA3 binding by ChIP-qPCR may also yield insights to how
chromatin affects TET1 recruitment.

4.3 TET1 and Human Imprinting Disorders
Given the findings that mice with Tet1 mutations are viable and fertile, yet have
abnormal germ cells and thus transmit imprinting defects to F1 offspring, the hypothesis
arises that TET1 may play a similar role in the etiology of human imprinting disorders.
While deleterious TET1 mutations have been described in the context of somatic
mutations in cancer (Li et al., 2016) and annotated in very rare instances in reference
human populations (1000 Genomes project, the Exome Aggregation Consortium [ExAC,
http://exac.broadinstitute.org], the Trans-Omics for Precision Medicine [TOPMed]
Program [https://www.nhlbi.nih.gov/science/trans-omics-precision-medicine-topmedprogram], and the Exome Sequencing Project [ESP,
http://evs.gs.washington.edu/EVS/]), to date, no mutations in TET1 have been reported
to affect imprinted gene expression in humans (see Table 3.1). If this hypothesis were
true, we would expect the following criteria in patients. First, because TET1 is
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responsible for the erasure of DNA methylation during primordial germ cell
reprograming, the hypothetical patient’s imprinting abnormality would be expected to be
hypermethylation. Secondly, this hypermethylation would be expected to affect only
maternal or paternal ICRs. Only in the case that both parents were homozygous for TET1
mutations, or if one allele was mutated and the other allele was encompassed by a larger
deletion, would we expect to see hypermethylation at both maternal and paternal ICRs.
While this scenario seems unlikely, we cannot rule out this possibility. Thirdly, the
patient would not be mosaic for the defect as this would indicate a problem postfertilization, as opposed to the germline. Fourthly, the defect would not be explained by
an underlying uniparental disomy (UPD) or a copy number variation at the ICR. Lastly,
it is possible that patients could have a single hypermethylated locus but could also show
abnormalities at more than one loci, such as has been reported in multi locus imprinting
disorders (MLID). However, while most MLID cases consist of epimutations, they tend
to fall under the category of loss of methylation and additionally tend to be mosaic
(Mackay and Temple, 2017).
To explore the hypothesis that TET1 plays a similar role in the etiology of human
imprinting disorders as we have shown in mice, I searched through the available
literature to determine if there are any patients that would satisfy the criteria outlined
above. Surprisingly, most imprinting disorders are explained by copy number variation
or uniparental disomy. Of those that are not explained by a deletion, duplication, or UPD
and are purely “epimutations” at an ICR, most cases are reported to be loss of
methylation as opposed to gain of methylation at ICRs (Court et al., 2013). Despite this,
there are indeed reports, albeit rare, of hypermethylation epimutations including 5-10%
of Beckwith–Wiedemann syndrome (BWS) with hypermethylation of H19, <1% of
hypermethylation in Prader-Willi syndrome (PWS), and <5% “epimutations” for
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Angelman syndrome (AS)(Elhamamsy, 2017; Mackay and Temple, 2017). Given these
numbers, I looked in the primary literature to find examples of patients that supported
our hypothesis.
In a cohort of 79 patients with growth restriction, four patients presented with
hypermethylation at the IGF2R ICR with no concurrent methylation changes at IC1
(Turner et al., 2010). While IGF2R only exhibits imprinted expression in human fetal
tissue and some Wilms’ tumors (Yotova et al., 2008), the hypermethylation of the ICR
and growth restricted phenotype of these patients would be consistent with
overexpression of IGF2R during development and possibly affecting postnatal growth as
a result. Further studies of these patients and their circulating levels of IGF2 as well as
levels of IGF2R are warranted (Turner et al., 2010). Additionally, in a cohort of 51
patients with PWS and 85 patients with AS, 19 PWS patients presented with
hypermethylation of the PWS-IC, the imprinting control region at the SNRPN locus in
humans (Ohta et al., 1999), with no underlying IC mutation. Intriguingly, microsatellite
analysis determined that all 19 of the abnormally methylated paternal alleles were
inherited from the grandmother, indicating a failure to erase in the paternal germline.
These authors calculated that given the 1% occurrence of epimutations in PWS cases,
which occur in 1 in 15,000 births, the likelihood of a sperm carrying an abnormally
hypermethylated imprint at the PWS locus is 1 in 1,500,000 sperm (Buiting et al., 2003).
Regardless of the rarity, these patients align with our hypothesis that abnormalities of
this nature could be due to mutations or changes in expression or activity of TET1 in the
germline. In contrast, the AS patients with epimutations not explained by underlying
deletions showed mosaicism as well as equal inheritance of the abnormal allele from
their grandmothers and grandfathers, indicating that TET1 was unlikely to underlie the
etiologies of these AS patients. Two independent studies found four, and four out of 56
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BWS patients, respectively, with hypermethylation at IC1 but no changes in KvDMR
methylation (Bliek et al., 2001; Smilinich et al., 1999). Therefore, there are clinical that
support the hypothesis that TET1 could be affecting a small but detectable proportion of
imprinting disorder patients.
Why have TET1 mutations not been reported in patients with imprinting
disorders? This may be due the order and types of testing that are currently used in the
clinical setting. For example, first pass molecular diagnoses are usually methylation
studies of a single imprinted locus in question (Grafodatskaya et al., 2017). If further
tests are required, they often are still single locus or single chromosome specific,
involving FISH to look for common, large deletions, other types of CNV analysis, single
gene mutation analysis, or UPD analysis, which is primarily performed by using
microsatellite markers across the chromosome (Brioude et al., 2018; Grafodatskaya et
al., 2017; Smith and Hung, 2017; Wakeling et al., 2016). When genome-wide
technologies are used, they are typically karyotypes, genome-wide methylation arrays, or
SNP arrays, which can detect uniparental disomy, (Court et al., 2013; Grafodatskaya et
al., 2017), all of which lack the sensitivity to detect point mutations or insertions and
deletions smaller than the size of an exon (Hjelm et al., 2010). Therefore, exomes are not
the diagnostic choice for imprinting disorders (van Zelst-Stams et al., 2014). In the more
limited cases where exomes are applied, common filtering strategies used will only
account for de novo, X-linked, or autosomal dominant or recessive inheritance patterns
that do not account for imprinted inheritance. Additionally, identification of a variant
can be confounded by presence of mosaicism in the parent in trio-based exome strategies
(Aten et al., 2016; Bodian et al., 2014; Palomares-Bralo et al., 2017). Indeed, because
TET1 mutations would be expected to present in a homozygous state in one unaffected
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parent and in the heterozygous state in the affected offspring, this alteration would likely
also be filtered out and remain undetected.
Having a molecular and clinical diagnosis for imprinting disorders is important
for multiple reasons. For families, determining the recurrence rate for future family
planning as well as for counseling other family members is crucial. Homozygous
alterations at the TET1 locus would lead to a very high recurrence rate for future
pregnancies, and while the affected child would not pose a risk of their children being
affected, their grandchildren could potentially be homozygous and thus greatgrandchildren would be at high risk again for having an imprinting disorder. Secondly,
being able to classify patients into subgroups can help with genotype-phenotype
associations. For example, certain subtypes of imprinting disorders require different
management strategies, such as in the case of hypermethylation at the H19 locus where
BWS patients have a higher risk of developing tumors compared patients with other
molecular causes of BWS (Grafodatskaya et al., 2017).
Given the evidence above, I recommend that in cases of imprinting disorders
characterized by hypermethylation, no underlying CNV, ICR deletion, or UPD, patients
should be tested for heterozygous alterations in TET1. If parent samples are available,
they should also undergo targeted TET1 testing. However, despite the possibility of TET1
potentially being a contributor to human imprinting disorders, it is also possible that this
is not the case. Tet1 homozygous null mutations are well tolerated in mice, but this may
not be the case in humans. Additionally, the reproductive challenges imposed by Tet1
mutations in female mice could be equally as bad or more severe in humans. Thus,
human TET1 alterations may contribute to impaired or complete infertility in mothers as
opposed to imprinting disorders in their children. Lastly, the ICRs regulated by TET1 in
humans and in mice may vary. Data from our lab and others demonstrates that in mice,
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TET1 does not regulate the demethylation of Snrpn in the germline. However, the
strongest evidence for TET1 to be playing a role is at the PWS-IC. Therefore, more work
is needed, in human PGC culture models for instance, to understand the similarities and
differences between mouse and human TET1 function. By exploring TET1 as a potential
cause of imprinting disorders, patients and families will benefit from not only the
knowledge of their mutation but the additional counseling and potential treatments that
may follow in the future.

3.4 Tet1 knockout by Tet1 knockout breeding
Previous evidence suggests it is possible to generate live pups from a Tet1-/-- by
Tet1-/- cross (Dawlaty et al., 2011; Yamaguchi et al., 2012). However, it has not been
ascertained whether these offspring have imprinting defects, such as DNA methylation
abnormalities at ICRs or loss of imprinting. These crosses would also shed light on
whether it is possible to have both hypermethylated maternal and paternal ICRs in the
same animal or if no combinations are seen, which abnormal ICR combinations could
produce a synthetic lethal effect. I hypothesize that the live born animals would have
only one or no imprinting defects. These animals may be the ones who escaped
inheriting multiple hypermethylated imprinted alleles, as we see in our Tet1-/- maternal
or paternal knockout crosses. To begin to address these questions, we mated Tet1-/-- by
Tet1-/- animals and measured both weight and litter size at birth. Controls for these
crosses were Tet1-/- sires with either Tet1+/+ females or Tet1+/- females. Our preliminary
data indicates that indeed, live embryos were generated by the Tet1-/-- by Tet1-/- breeding
scheme (Table 3.2). Comparing our pups to weight and litter data from offspring of
Tet1+/+ by Tet1-/- crosses, we see no differences in weight or litter size (Fig. 3.5). However,
the sample size will need to be significantly increased in order to determine if there are
any true effects. Additionally, it may be informative to look at early embryonic stages as
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changes in proportions of affected animals were detected at certain loci in our maternal
or paternal Tet1-/- matings.
The next steps for this project would be to measure DNA methylation by
pyrosequencing in the tissues from pups. We could quantify the presence or absence of
any ICR alterations, as well as correlate hypermethylation in one locus to the other
imprinted loci. Additionally, to begin to understand not only changes in DNA
methylation but also imprinted gene expression, the Tet1 mice should be crossed into the
C7 background for multiple generations. Thus, the F1 hybrid offspring would now have
allele-specific SNPs, allowing for allele-specific expression to be determined.
Relatedly, another remaining question concerns how these imprinting
abnormalities persist through generations. I hypothesize that a Het produced from a
Tet1-/- mouse mated to a WT mouse would have normal DNA methylation levels in their
gametes and normal monoallelic expression of imprinted genes if they were to be mated
to another Het or WT mouse. This is because the PGCs in the next generation would now
have a WT copy of Tet1 during DNA demethylation and thus the error should correct
itself. The exception would be if the amount of WT TET1 is insufficient to demethylate
two alleles instead of just one, in which case, this result would indicate that Tet1 may be
haploinsufficient in certain cases. This would also support data from Chapter 2 where we
very rarely saw hypermethylated control offspring coming from a Het parent.

3.5 Conclusion
These proposed experiments will reveal key insights into TET1 recruitment at
ICRs and how this protein promotes proper monoallelic imprinted gene expression.
Additionally, my investigation through the literature reveals a rare, but possible link
between TET1 abnormalities and human imprinting disorders. Overall, these studies will
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shed light on proper epigenetic reprogramming as a key developmental process crucial
for human health.
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Figure 3.1. Tet1;Oct4-eGFP mouse crossing strategy. The left hand column
describes the genotype of interest and the percentage of mice that will have the resultant
alleles based on the cross depicted above it. The right hand column depicts the overall
percentage of mice with the genotype of interest, taking into account both alleles. Green
circles represent EGFP positive primordial germ cells.
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A.

B.

Figure 3.2. E13.5 PGC sorting using the EGFP reporter. (A) Negative control
(water) plots and (B) E13.5 PGCs. First panel represents viable cells. Second panel
indicates GFP signal on the x-axis and count on the y-axis. Third panel shows where M1
gated cells fall in the P2 gate in the first panel, indicating these cells are both viable and
GFP+. GFP+ PGCs are the smaller peak, designated M1. 10% of the cells sorted are EGFP
positive. Overall, for this particular sample, about 6,500 PGCs are EGFP positive from
the two gonads from one embryo.
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A.

B.

C.

Figure 3.3. TET1 is not localized to ICRs but is localized at secondary DMRs
in mouse ESCs.
(A) mm9 UCSC genome browser screen shot showing the H19 gene, dark blue, and the
corresponding intergenic ICR [highlighted in a yellow box (not to scale) and by the CTCF
peaks shown in light blue]. There are no TET1 peaks in this region. (B) The Peg3 locus
with the ICR highlighted in yellow box, not to scale. TET1 peaks are visible in this screen
shot (black boxes) but not at the ICR. (C) The Cdkn1c gene is shown in dark blue, CpG
islands are shown in green, corresponding to the secondary DMR at this locus. TET1 and
OGT peaks localize across the gene body and overlap annotated CpG islands in ESCs.
ChIP-seq data from (Williams et al., 2011).
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Figure 3.4. Models of how H3K9me2/3 might repress TET1, leading to earlyand late-demethylated ICRs in PGCs and how perturbing these modifications using
dCas9-fusions could lead to a switch in DNA methylation erasure timing in in vitro
PGCLCs.
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Frequency: The variant is reported to be polymorphic in at least one sample.
ExAC: The variant was discovered in the Exome Aggregation Consortium
ESP: The variant was discovered in the Exome Sequencing Project
1000 Genomes: The variant was discovered in the 1000 Genomes Project
HapMap: The variant is polymorphic in at least one HapMap panel
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Figure 3.5. Preliminary data regarding differences in (A) litter size or (B)
weight (g) of KO x KO pups. No statistical differences are detected by One-way
ANOVA analyses. mWT data from the Tet1+/+ (C7) x Tet1-/- (B6) crosses described in
chapter two for comparison, whereas all other data is B6 x B6.
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CHAPTER 4: MATERIALS AND METHODS
4.1 Animals
Tet1 mice were purchased from The Jackson Laboratory (Dawlaty et al., 2011:
B6;129S4-Tet1tm1.1Jae/J, Stock No: 017358). Mice were backcrossed at least 4
generations to C57BL/6J (Stock No: 000664) before analysis with the exception of
sperm samples. Tet1/2 double knockouts have the same allele as the Tet1 single
knockouts and the Tet2 allele was originally generated by Li et al., 2011. Tet1 knockout
mice were generated by heterozygous mating or by mating Tet1 heterozygotes on a Oct4GFP heterozygous background (Lengner et al., 2007, B6;129S4-Pou5f1tm2Jae/J, Stock
No. 008214). Tet1 animals were genotyped by lysing ear punches in fast lysis buffer A (25
mM NaOH, 0.2 mM EDTA, pH 8.0) at 95°C for one hour and subsequently adding an
equal volume of fast lysis buffer B (40 mM Tris HCl). 2 µL of genomic DNA was used for
genotyping PCR reactions. CAST7 mice are maintained in our mouse colony. Timed
mating was determined by checking for a vaginal sperm plug. 12 PM (noon) was taken to
be E0.5 on the day the plug was observed. Embryos were also visually staged upon
dissection. All studies were performed in accordance with procedures approved by the
University of Pennsylvania’s Institutional Animal Care and Use Committee.

4.2 Germ Cell Collection
4.2.1 Oocytes

Pools of 20-100 germinal vesicle-stage oocytes were collected from the ovaries of
one 26-28 day-old mouse. Cumulus cells were removed from oocytes by mouth pipetting
and transferring into clean drops of M2 medium (Sigma-Aldrich, catalog number:
M7167) supplemented with a final concentration of 2.5 µM milrinone. When necessary,
oocytes were briefly incubated in a drop of M2 media containing a final concentration of
97

0.3 mg/mL of hyaluronidase to remove cumulus cells. Oocytes were snap frozen in liquid
nitrogen.
4.2.2 Sperm

Adult male mice (> 8 weeks of age) were mated with a female for at least two days
and then isolated for at least two days. After sacrifice, the epididymis was dissected.
Epididymal sperm was collected on a needle and then incubated in room temperature
PBS. Motile sperm were collected by removing the supernatant. Sperm were counted on
a hemocytometer and then pelleted. The PBS was removed from the sperm pellet and
was snap frozen in liquid nitrogen.
4.2.3 PGCs

E13.5 or E12.5 concepti were removed from the uterine horn and from the
amniotic sac. The placenta was separated and each embryo was placed in ice cold PBS in
individual wells of a 12 well plate. Gonads were isolated and moved to 1.5 mL eppendorf
tubes on ice. When all gonads were collected, they were gently spun down and the
remaining PBS was removed. 1 mL of 0.05 % Trypsin/EDTA was added to the gonads
and incubated at 37 degrees either rotating in the hybridization oven or shaking in the 37
degree water bath. After incubation, the gonads were further dissociated by using a 1 mL
syringe with an 18-guauge needle (5 times up and down) followed by a 23 gauge needle
(5 times up and down). The reaction was then quenched with 0.5 mL of HBSS with 1%
BSA. The tubes were spun down for 10 minutes at 4 degrees C, followed by another wash
in the same solution, and finally, suspended in 0.5 mL of the HBSS with 1% BSA.
Immediately before flow cytometry, the cell suspension went through five more times
through a 23-gauge needle. Cell counts were additionally conducted independently of the
flow cytometer using a hemocytometer at 10X magnification. Concurrent genotyping
took place using embryonic tail or limb.
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4.3 Tissue Homogenization
Embryonic tissue samples were homogenized in tail lysis buffer (50 mM TrisHCl, pH 8, 0.5% SDS, 100 mM EDTA, pH 8) with a needle and syringe. P0 newborn
brain and tongue were homogenized in tail lysis buffer with a polytron (Kinematica,
Model PT 10-35 GT). P0 newborn livers were divided upon dissection and one half was
homogenized with a needle and syringe directly in TRIzol Reagent, and the other half
was homogenized in tail lysis buffer using the polytron and subsequently processed for
DNA.

4.4 RNA and cDNA conversion
Tissue lysate was added to TRIzol reagent (Thermo Fisher Scientific, Cat #
15596026) and mixed thoroughly. TRIzol extraction was performed as specified in the
manufacturer’s protocol. RNA quantity was determined by nanodrop (ND-1000
Spectrophotometer) and RNA quality was assessed by running 500 ng on an agarose gel
and confirming intact rRNA bands at the expected intensity ratio. Only samples with
intact RNA were used for further analysis. 500-1000 ng of total RNA was treated with 1.5
µL of RQ1 RNase-free DNAse (Promega Cat # M6106) for 30 minutes at 37°C followed
by addition of 1.5 µL of Stop Solution and incubated for 10 minutes at 65°C. Two-thirds
of the treated RNA was put into a 20 µL cDNA conversion using SuperScript III Reverse
Transcriptase (RT) (Thermo Fisher Scientific, Catalog number: 18080093) and random
primers (Sigma-Aldrich, catalog number 11034731001). The remaining one-third of the
treated RNA was used in a negative RT reaction.

4.5 qPCR Analysis
A cDNA dilution series was used to make a standard curve from which qPCR
primer amplification efficiencies were determined using Power SYBR Green Master Mix
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(ThermoFisher Scientific, catalog number 4368577). For primers and cycling conditions,
see Tables S8,S9. cDNA was diluted to a final amount of 5 ng/well for total expression
analysis. Samples were run in triplicate on a 7900 Fast Real-Time PCR System (Applied
Biosystems) with non-template controls for each gene. Melt-curve analysis was
performed to ensure specific amplification. For quality control, any individual Ct value
within a triplicate that was > 0.5 Ct from the other two was removed. Data was
normalized to the geometric mean of three housekeeping genes: Rplp0, Nono, and
Rpl13a. The control animals were averaged and graphed with the individual Tet1 mutant
animals per qPCR plate.

4.6 Allele-Specific Expression Analysis
10 ng of cDNA were used per PCR reaction. For primers and PCR conditions, see
Tables S8,S9. Linear range of amplification was determined for each tissue and
developmental stage. Each assay used a different restriction enzyme: H19: Cac8I 37°C
for 3 hours, heat-inactivated at 65°C for 20 minutes (NEB, Cat. No. R0579S); Igf2:
MluCI, 37°C for 3 hours, no heat-inactivation (NEB, Cat. No. R0538S); Peg3: MnlI 37°C
for 3 hours, heat-inactivated at 65°C for 20 minutes (NEB, Cat. No. R0163S); Cdkn1c:
TaqαI 65°C for 1 hour, heat-inactivated for 20 minutes at 80°C (NEB, Cat. No. R0149S);
Kcnq1ot1: StuI 37°C for 3 hours, no heat-inactivation (NEB, Cat. No. R0187S). Digests
were performed using the supplied buffer and 3-8 µL of PCR in a 20 µL reaction volume.
Digests were run on 7% or 12% polyacrylamide gels. Band densitometry was analyzed
using ImageJ software. Complete digestion was assessed by running pure parental strain
cDNA PCR product digests as controls. Snrpn allele-specific analysis was performed
using the LightCycler Real-Time PCR system (Roche) as described in Mann et al., 2004
with the following modifications: illustra PuReTaq Ready-To-Go PCR Beads were used
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(GE healthcare, catalog number 27-9559-01) and hybridization probes were purchased
from IDT.

4.7 DNA extraction
Tissue lysate was incubated overnight with Proteinase K (Sigma-Aldrich, P2308)
at a final specific activity of 180 U/mL at 37°C. Sperm pellets were resuspended in sperm
lysis buffer (20 mM Tris-HCl, pH 8, 200 mM NaCl, 20 mM EDTA, 4% SDS) with the
addition of 5 µL b-mercaptoethanol and Proteinase K at a final specific activity of 180
U/mL at 55°C overnight. DNA was subsequently phenol-chloroform extracted, followed
by ethanol precipitation and resuspended in dH2O or TE (10 mM Tris-HCL pH 8, 0.5
mM EDTA) buffer.

4.8 Bisulfite Treatment
1000 ng of sperm and mouse tissue DNA was bisulfite treated using the EpiTect
Bisulfite Kit (Qiagen Cat No./ID: 59104) and eluted in 20 µL of the supplied EB buffer.
Oocyte pools were directly lysed using the LyseAll Lysis Kit (Qiagen) and bisulfite
converted using the EpiTect Plus Bisulfite Kit (Qiagen, Cat No./ID: 59124). Oocyte
bisulfite-treated DNA was resuspended in 13 µL of the supplied EB buffer.

4.9 Pyrosequencing
Pyrosequencing PCRs and sequencing reactions were carried out as described in
de Waal et al., 2014. For primers and PCR conditions, see Tables S8,S9. Briefly, 1-2 µL of
bisulfite treated DNA was used to set up pyrosequencing PCRs using the PyroMark PCR
kit (Qiagen, Cat. No. 978703) using locus-specific primers. 2-4 µL of PCR was used in
each pyrosequencing reaction and sequenced on the Q96 machine. Pyrosequencing
peaks were manually inspected for sequencing errors and matching to the reference
expected peaks. CpGs that did not pass these quality control criteria were excluded from
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the final analysis. Oocyte methylation data was further subjected to the following criteria
to ensure there was no somatic cell contamination: For any given sample, two maternally
methylated ICRs had to have an average % methylation ≥ 90% and must have amplified
at least H19/Igf2 or IG-DMR. Samples that did not meet these criteria were excluded
from the final analysis (Table S1).

4.10 Bisulfite, Clone, and Sequencing Analysis
Nested PCR reactions were performed using bisulfite-treated DNA (Tables S8,S9)
as previously described (Market-Velker et al., 2010) with the following exceptions:
illustra PuReTaq Ready-To-Go PCR Beads were used (GE healthcare, catalog number
27-9559-01). 1 µL of bisulfite DNA was used for the first round of PCR, while 4 µL of first
round PCR seeded the second round PCR reaction. Two independent PCR reactions were
set up for both first and second round PCRs. Second round PCR products were cloned
using StrataClone PCR Cloning Kit (Agilent). At least 20 colonies per plate were picked
and analyzed for the insert using EcoRI digestion. Clones containing the correct size
insert were submitted for Sanger Sequencing analysis at the University of Pennsylvania
DNA sequencing facility. Sequences were analyzed using the QUMA website (Kumaki et
al., 2008, quma.cdb.riken.jp/).

4.11 Statistics
All analyses were completed using the Graphpad PRISM software with the
following exceptions: Variance (σ2 = [Σ(xi - x̄)^2]/[n-1]) was calculated in Microsoft
Excel using the VAR.S function, and the Fligner-Killeen Test of Homogeneity of
Variances was calculated in R. Chi-square and Fisher’s exact test were calculated on the
Graphpad website (https://graphpad.com/quickcalcs/chisquared1.cfm,
https://graphpad.com/quickcalcs/contingency1.cfm). Sample size was determined by
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conducting smaller pilot studies. The investigators were not blinded to the identity of the
samples during analysis.
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Table 4.1: List of primers used for each assay in this study.
Gene/Region
Primer
Primer Sequence
Tet1
13037
TCAGGGAGCTCATGGAGACTA
Tet1
13038
TTAAAGCATGGGTGGGAGTC
Tet1
13039
AACTGATTCCCTTCGTGCAG
Kdm5c/Kdm5d
Smc1
TGAAGCTTTTGGCTTTGAG
Kdm5c/Kdm5d
Smc2
CCACTGCCAAATTCTTTGG
H19
H19 F
GTCTCGAAGAGCTCGGACTG
H19
H19 R
ACTGGCAGGCACATCCAC
Igf2
Igf2 F
CGCTTCAGTTTGTCTGTTCG
Igf2
Igf2 R
GCAGCACTCTTCCACGATG
Meg3/Gtl2
Meg3 F
TTGCTGTTGTGCTCAGGTTC
Meg3/Gtl2
Meg3 R
ATCCTGGGGTCCTCAGTCTT
Dlk1
Dlk1 F
CGGGAAATTCTGCGAAATAG
Dlk1
Dlk1 R
TGTGCAGGAGCATTCGTACT
Rplp0
Arrpo F
TCCCACTTACTGAAAAGGTCAAG
Rplp0
Arrpo R
TCCGACTCTTCCTTTGCTTC
Rpl13a
Rpl13a F
ATCCCTCCACCCTATGACAA
Rpl13a
Rpl13a R
GCCCCAGGTAAGCAAACTT
Nono
Nono F
GCTCGTGAGAAGCTGGAGAT
Nono
Nono R
TTCTTGACGTCTCATCAAATCC
H19
HE2 (F)
TGATGGAGAGGACAGAAGGG
H19
HE4 (R)
TTGATTCAGAACGAGACGGAC
Igf2
Igf2 -18
ATCTGTGACCTCCTCTTGAGCAGG
Igf2
Igf2 -20
GGGTTGTTTAGAGCCAATCAA
Cdkn1c
p57-L
GCCAATGCGAACGGTGCG
Cdkn1c
p57-4
TACACCTTGGGACCAGCGTACTCC
Peg3
PG4
ATGCCCACTCCGTCAGCG
Peg3
PG7
GCTCATCCTTGTGAACTTTG
Kcnq1ot1
Lit1 F
ATTGGGAACTTGGGGTGGAGGC
Kcnq1ot1
Lit1 R
GGCACACGGTATGAGAAAAGATTG
Snrpn
Sn1 (F)
CTCCACCAGGAATTAGAGGC
Snrpn
Sn3 (R)
GCAGTAAGAGGGGTCAAAAGC
Snrpn
SnMut (Snrpn sensor probe)
GAAGCATTGTAGGGGAAGAGAA-fluorescein
Snrpn
SnAnc (Snrpn anchor probe)
LC-Red640-GGCTGAGATTTATCAACTGTATCTTAGGGTC-P
H19/Igf2 ICR
H19/Igf2 ICR F
GGGTAGGATATATGTATTTTTTAGGTTG
H19/Igf2 ICR
H19/Igf2 ICR R-biotinylated
CTCATAAAACCCATAACTATAAAATCAT
H19/Igf2 ICR
H19/Igf2 ICR Sequencing
TGTAAAGATTAGGGTTGT
IG-DMR
IG-DMR F
GTGGTTTGTTATGGGTAAGTTT
IG-DMR
IG-DMR R-biotinylated
CCCTTCCCTCACTCCAAAAATTAA
IG-DMR
IG-DMR sequencing
GTTATGGATTGGTGTTAAG
Snrpn ICR
Snrpn F
GGTAGTTGTTTTTTGGTAGGATAT
Snrpn ICR
Snrpn R- biotinylated
ACTAAAATCCACAAACCCAACTAACCT
Snrpn ICR
Snrpn Sequencing
GTGTAGTTATTGTTTGGGA
Peg3 ICR
Peg3 F
GGTTTTTAAGGGTAATTGATAAGG
Peg3 ICR
Peg3 R- biotinylated
CCCTATCACCTAAATAACATCCC
Peg3 ICR
Peg3 Sequencing
AATTGATAAGGTTGTAGATT
KvDMR
KvDMR F
TTTTGTGTGATTTTATTTGGAGAGT
KvDMR
KvDMR R-biotinylated
CCTCAAAACCACCCCTACT
KvDMR
KvDMR Sequencing
GTAAGTATTTAAGGTTAGAAGTAGA
Peg1/Mest ICR
Peg1/Mest ICR F
GGAGGTTTTATATAAGTATTTGTTTTT
Peg1/Mest ICR
Peg1/Mest ICR R-biotinylated
ACCACCCAACTAACACTAAA
Peg1/Mest ICR
Peg1/Mest Sequencing
GGTTTTATATAAGTATTTGTTTTTT
Peg3 ICR
Peg3A-BL (1st round)
TTTTGATAAGGAGGTGTTT
Peg3 ICR
Peg3D-BL (1st round)
ACTCTAATATCCACTATAATAA
Peg3 ICR
Peg3B-BL (2nd round)
AGTGTGGGTGTATTAGATT
Peg3 ICR
Peg3C-BL (2nd round)
TAACAAAACTTCTACATCATC
H19/Igf2 ICR
GAGTATTTAGGAGGTATAAGAATT
BMsp2t1 (H19 A) (1st round)
H19/Igf2 ICR
ATCAAAAACTAACATAAACCCCT
BHha1t3 (H19 D) (1st round)
H19/Igf2 ICR
Bmsp2t2c (H19 B) (2nd round)
GTAAGGAGATTATGTTTTATTTTTGG
H19/Igf2 ICR
BHha1t4ct (H19 C) (second round) CTAACCTCATAAAACCCATAACTAT

Assay
References
Tet1 Genotyping
The Jackson Laboratory
Tet1 Genotyping
(https://www2.jax.org/protocolsdb/f?p=116:5:0::NO:5:P5_M
Tet1 Genotyping
ASTER_PROTOCOL_ID,P5_JRS_CODE:25442,017358)
Sex Genotyping
(Jay and Ciaudo, 2013)
Sex Genotyping
qPCR
(Thorvaldsen et al., 2006)
qPCR
qPCR
qPCR
qPCR
qPCR
(Lin et al., 2011)
qPCR
qPCR
qPCR
qPCR
qPCR
qPCR
(Bougault et al., 2008)
qPCR
qPCR
(Plasschaert and Bartolomei, 2015)
Allele-Specific Expression
(Thorvaldsen et al., 2006)
Allele-Specific Expression
Allele-Specific Expression
Allele-Specific Expression
(Fortier et al., 2008)
Allele-Specific Expression
Allele-Specific Expression
(Weaver et al., 2010)
Allele-Specific Expression
Allele-Specific Expression
(Bhatnagar et al., 2014)
Allele-Specific Expression
Allele-Specific Expression
(Rivera et al., 2008)
Allele-Specific Expression (Light Cycler)
Allele-Specific Expression (Light Cycler)
(Szabo and Mann, 1995)
Allele-Specific Expression (Light Cycler Probe)
Allele-Specific Expression (Light Cycler Probe)
Pyrosequencing PCR
Pyrosequencing PCR
Pyrosequencing Sequencing Primer
Pyrosequencing PCR
Pyrosequencing PCR
Pyrosequencing Sequencing Primer
Pyrosequencing PCR
Pyrosequencing PCR
Pyrosequencing Sequencing Primer
(de Waal et al., 2014)
Pyrosequencing PCR
Pyrosequencing PCR
Pyrosequencing Sequencing Primer
Pyrosequencing PCR
Pyrosequencing PCR
Pyrosequencing Sequencing Primer
Pyrosequencing PCR
Pyrosequencing PCR
Pyrosequencing Sequencing Primer
Bisulfite Sequencing PCR
Bisulfite Sequencing PCR
(Mann et al., 2004)
Bisulfite Sequencing PCR
Bisulfite Sequencing PCR
(Market-Velker et al., 2010)
Bisulfite Sequencing PCR
Bisulfite Sequencing PCR
(Tremblay et al., 1997)
Bisulfite Sequencing PCR
Bisulfite Sequencing PCR
(Ideraabdullah et al., 2014)

(Jay and Ciaudo, 2013)(Lin et al., 2011; Thorvaldsen et al., 2006) (Plasschaert and Bartolomei, 2015)(Bhatnagar et al.,
2014; de Waal et al., 2014; Fortier et al., 2008; Ideraabdullah et al., 2014; Mann et al., 2004; Market-Velker et al., 2010;
Rivera et al., 2008; Szabo and Mann, 1995; Tremblay et al., 1997; Weaver et al., 2010)
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Table 4.2: List of PCR cycling conditions for each PCR used in this study.
Assay

Thermal Cycler

PCR conditions

Annealing
Temperature (TA), °C

No. of cycles

Tet1

Thermo Electron Hybaid
PCR Express Thermal
Cycler

2 min denaturation at 94°C; number of cycles of [15 s
at 94°C, 15 s at TA, and 40 s at 72°C]

60

35

Smc

BioRad C1000 Touch
Thermal Cycler

55

40

qPCR: All genes

7900HT Fast Real-Time
PCR System

-

40

Allele-Specific
H19

BioRad C1000 Touch
Thermal Cycler

58

21-31

Allele-Specific
Igf2

BioRad C1000 Touch
Thermal Cycler

60

24-32

Allele-Specific
Cdkn1c

BioRad C1000 Touch
Thermal Cycler

60

25-30

Allele-Specific
Peg3

BioRad C1000 Touch
Thermal Cycler

60

29-34

Allele-Specific
Lit1/Kcnq1ot1

BioRad C1000 Touch
Thermal Cycler

64

32-34

Allele-Specific
Snrpn

Roche LightCycler 1.5

-

Amplification: 45;
Melt: 3; Cooling: 1

Pyrosequencing

BioRad C1000 Touch
Thermal Cycler

50

25

53

35

50

25

58

35

Peg3 Bisulfite

H19 Bisulfite

BioRad C1000 Touch
Thermal Cycler

BioRad C1000 Touch
Thermal Cycler

5 min denaturation at 95°C; number of cycles of [15 s
at 95°C, 1 min at TA, and 1 min at 72°C]; 7 min
extension at 72°C
2 min hold at 50°C; 10 min hold at 95°C; number of
cycles of [15 s at 95°C, 1 min at 60°C]; Melting Curve:
95°C for 15 s, 60°C for 15 s, 95°C for 15 s.
2 min denaturation at 95°C; number of cycles of [15 s
at 95°C, 20 s at TA, and 20 s at 72°C]; 5 min
extension at 72°C
2 min denaturation at 94°C; number of cycles of [20 s
at 94°C, 20 s at TA, and 20 s at 72°C]; 5 min
extension at 72°C
2 min denaturation at 95°C; number of cycles of [15 s
at 95°C, 20 s at TA, and 20 s at 72°C]; 5 min
extension at 72°C
2 min denaturation at 94°C; number of cycles of [20 s
at 95°C, 20 s at TA, and 20 s at 72°C]; 5 min
extension at 72°C
2 min denaturation at 95°C; number of cycles of [20 s
at 95°C, 20 s at TA, and 50 s at 72°C]; 5 min
extension at 72°C
Amplification: 95°C 1 s (20°C/s), 50°C, 15 s (20°C/s),
72°C, 6 s (20°C/s); Melt: 95°C, 4 min (20°C/s), 35°C,
3 min (20°C/s), 40°C, 1 min (20°C/s), 45°C, 1 min
(20°C/s), 85°C, 0 s, (0.5°C/s); Cooling: 40°C 30 s,
(20°C/s)
(Hur et al., 2016)
First Round: 5 min denaturation at 94°C; number of
cycles of [94°C for 30 s, TA for 30 s, 72°C for 1 min];
10 min extension at 72°C
Second Round: 5 min denaturation at 94°C; number of
cycles of [94°C for 30 s, TA for 30 s, 72°C for 1 min];
10 min extension at 72°C
First Round: 5 min denaturation at 94°C; number of
cycles of [94°C for 30 s, TA for 30 s, 72°C for 1 min];
10 min extension at 72°C
Second Round: 5 min denaturation at 94°C; number of
cycles of [94°C for 30 s, TA for 30 s, 72°C for 1 min];
10 min extension at 72°C
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Table 4.3 Complete PCR protocols with linear range information for imprinted genes
Cdkn1c
Thermal cycler (Deg C, time (min)
Cycle #
MM
/rxn
dH2O
9.5
57-4 (10 uM)
1
57-L (10 uM)
1
GoTaq
12.5
cDNA
1 each
Lit1/Kcnq1ot1
MM
/rxn
dH2O
8.84
Lit1-F (15 uM)
0.83
Lit1-R (15 uM)
0.83
GoTaq
12.5
cDNA
1 each
H19
MM
/rxn
dH2O
10.5
HE2 (25 uM)
0.5
HE4 (25 uM)
0.5
GoTaq
12.5
cDNA
1 each
Igf2
MM
/rxn
dH2O
10.9
Igf2-18 (25 uM)
0.3
Igf2-20 (25 uM)
0.3
GoTaq
12.5
cDNA
1 each
Peg3
MM
/rxn
dH2O
10.5
PG4
0.5
PG7
0.5
GoTaq
12.5
cDNA
1 each

95
95
60
72
72
12
Thermal cycler
95
95
64
72
72
12
Thermal cycler
95
95
58
72
72
12
Thermal cycler
94
94
60
72
72
12
Thermal cycler
94
94
60
72
72
12

2:00
0:15
0:20
0:20
5:00
∞
2:00
0:20
0:20
0:50
5:00
∞
2:00
0:15
0:20
0:20
5:00
∞
2:00
0:20
0:20
0:20
5:00
∞
2:00
0:20
0:20
0:20
5:00
∞

E10.5
E12.5
P0 Brain
P0 Tongue
P0 Liver
Cycle #
E10.5
E12.5
P0 Brain
P0 Tongue
P0 Liver

30X
30X
25X
30X

Reference

Enzyme

4- pg 30
8 -pg 30
8 -pg 30
8 -pg 30

Taqα I
65º C
1 hour
heat inact
20 min, 80º C

Reference

33X
32X
32X

BC rotation pg 21
BC rotation pg 21
BC rotation pg 21

Enzyme
StuI
37ºC
3 hours
heat inact
None

Cycle #
EM E10.5
26X
PL E10.5
24X
E12.5
31X
P0 Brain
28X
P0 Tongue
21-22X
P0 Liver
22X
Cycle #
(EM & PL) E10.5
32X
E12.5
25X
P0 Brain
26X
P0 Tongue
24X
P0 Liver
24X

Reference
6- pg 32
6- pg 32
4- pg 30
8 -pg 30
8 -pg 30
8 -pg 30
Reference
6- pg 35
4- pg 121
8 -pg 30
8 -pg 30
8 -pg 30

Enzyme
Cac8I
37ºC
3 hours
heat inact
20 min, 65° C

Cycle #
E10.5
E12.5
P0 Brain
32X
P0 Tongue
29-30X
P0 Liver
32X

Reference

Enzyme
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BC rotation pg 21
3- pg126
BC rotation pg 21

Enzyme
MluCI
37ºC
3 hours
heat inact
None
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